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EXPLORING PERSONAL GROWTH IN
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by
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ABSTRACT
This exploratory study described levels of personal growth and examined
relationships among personal growth, demographic, clinical, and cognitive factors in a
convenience sample (N = 103) of community-residing adults with New York Heart
Association (NYHA) functional class II-IV heart failure (HF). The study was guided by
Mishel’s reconceptualized uncertainty in illness theory and Tedeschi and Calhoun’s posttraumatic growth model. The following research questions were addressed: (1) Do adults
living with NYHA class II-IV HF report personal growth following their diagnosis of
HF? (2) To what extent are age, sex, ethnicity, disease severity, time since diagnosis,
symptom status, and uncertainty levels associated with personal growth in individuals
with HF? and (3) Which variables (age, sex, ethnicity, disease severity, time since
diagnosis, symptom status, or uncertainty levels) make independent contributions to
personal growth in individuals living with NYHA class II-IV HF? Participants completed
a demographic and clinical survey, the Posttraumatic Growth Inventory (PTGI), the
Mishel Uncertainty in Illness Scale-Community Version, and the Memorial Symptom
Assessment Scale–Heart Failure. Participants reported moderate levels of personal
growth (M = 48.6, SD = 28.6). There were no significant differences in personal growth
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by sex, ethnicity, or disease severity. Personal growth had a weak, negative correlation
with age (r = –.20, p < .05) and a weak, positive correlation with symptom burden (r =
.20, p < .05). Uncertainty was positively correlated with symptom burden (r = .49, p <
.01) and disease severity (r = .28, p < .01), but was not significantly correlated with PTGI
scores. A hierarchical regression model that included age, sex, ethnicity, NYHA
classification, years since diagnosis, uncertainty, and symptom burden did not account for
significant variance in PTGI scores. Findings provide foundational knowledge to guide
future study of personal growth in HF and add to the overall literature on personal growth
in relation to uncertainty and symptoms within chronic illness.
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CHAPTER 1
INTRODUCTION

Currently, more than 5 million Americans are living with a diagnosis of heart
failure (HF), and by 2030, this population is expected to increase by 3 million (Go et al.,
2013). HF is a chronic, progressive disease that is associated with an unpredictable
disease trajectory, significant symptom burden, increased rates of anxiety and depression,
poor quality of life, decreased life expectancy, and increased health-care costs (Adler,
Goldfinger, Kalman, Park, & Meier, 2009). National guidelines that address the diagnosis
and treatment of HF largely focus on disease-modifying interventions based on a
biomedical model of care (Heart Failure Society of America, 2010a, 2010b; Jessup et al.,
2009). To date, the majority of research conducted with this population has focused on
the adverse physical and psychosocial effects of living with a diagnosis of HF. A growing
body of research suggests that people living with serious illness may also report personal
growth and positive outcomes (Barskova & Oesterreich, 2009). Major gaps in the
literature exploring personal growth in patients with HF exist. A better understanding of
personal growth and factors that contribute to it may help to supplement traditional HF
management programs and inform models, such as palliative approaches, that are being
investigated to provide more holistic, supportive care to this population (Bekelman,
Nowels, Allen et al., 2011; Bekelman, Nowels, Retrum et al., 2011; Goodlin, 2009;
Hupcey, Penrod, & Fenstermacher, 2009). The purpose of this exploratory study was to
describe levels of personal growth in HF and to examine the relationship between
relevant demographic, clinical, and cognitive variables and personal growth.
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HF: Epidemiology, Pathophysiology, and Demographics
HF is a complex condition resulting from structural cardiac changes that impact
the ability of the heart to pump or fill, limiting its ability to provide adequate cardiac
output and/or to support venous return, ultimately reducing the heart’s ability to meet the
basic metabolic demands of the body (Kemp & Conte, 2012). An insult to the
myocardium arising from any of the following cardiac pathologies can lead to the loss of
functioning myocardial cells and trigger the development of HF: coronary artery disease
(CAD), myocardial infarction (MI) or chronic ischemia, hypertension (HTN), valvular
heart disease, cardiomyopathies, or, less commonly, myocardial injury due to infection,
toxins, or sustained dysrhythmias (Kemp & Conte, 2012; Ramani, Uber, & Mehra, 2010).
Modifiable risk factors for HF include those that are associated with the development of
CAD, HTN, and/or cardiomyopathies and include factors such as diabetes, dyslipidemia,
obesity, smoking, and alcohol or drug abuse. Advancing age is the primary
nonmodifiable risk factor for HF (Jessup et al., 2009).
By age 40, both men and women have a 20% lifetime risk of developing HF (Go
et al., 2013). The incidence of HF increases for both sexes after the age of 65 (Go et al.,
2013). According to the U.S. Department of Health and Human Services (2014), the
number of people aged 65 years and older is expected to reach 72.1 million by the year
2030, contributing to a growing prevalence of HF. With advances in cardiac care, such as
the use of better drugs, stents, and cardiac devices, people who might have died from an
MI in the past are now living longer and may eventually be diagnosed with HF. Thus,
increases in life expectancy generally, as well as improvements in cardiac care and
improvements in diagnostic capabilities, have all contributed to increasing the number of
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people living with HF. Despite improvements in survival after an HF diagnosis, 50% of
people diagnosed with this disease die within 5 years (Go et al., 2013). Over time, many
with the diagnosis will progress to advanced stages of HF (Jessup et al., 2009; Stuart,
2007). In the United States, the risk of developing HF is highest in African Americans,
followed by Hispanics, non-Hispanic Whites, and persons of Chinese heritage; in general,
HF events are higher in men than in women until age 65 (Go et al., 2013).
Providers diagnose HF as systolic, diastolic, or mixed systolic and diastolic,
according to the primary pathology of the left ventricle underlying the development of
HF. Systolic dysfunction describes the inability of the left ventricle to effectively contract
or pump and is present when the left ventricular ejection fraction (the percentage of blood
volume ejected from the left ventricle per heartbeat) is less than 40%; diastolic
dysfunction describes the inability of the ventricles to relax or fill adequately during
diastole (Kemp & Conte, 2012). Changes in myocardial fiber function lead to dilation or
hypertrophy of the cardiac chambers and stimulate a neurohormonal reaction involving
the release of catecholamines (norepinephrine and epinephrine) and vasopressin, as well
as activation of the renin-angiotensin-aldosterone axis. This response initially serves as a
compensatory mechanism to support cardiac output and perfusion, but over time, results
in cardiac cell death and further hypertrophy, leading to ventricular remodeling (a change
in the size, shape, composition, or function of the ventricle) and worsening contractile
dysfunction (Ramani et al., 2010). Other neurohormones that are elevated in HF include
the natriuretic peptides and endothelium-derived vasoactive agents (which promote
compensatory vasodilation), and various cytokines (Kemp & Conte, 2012).
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Left ventricular HF is primarily associated with pulmonary signs and symptoms.
Worsening left ventricular HF can lead to right ventricular HF, resulting in venous
congestion in the systemic circulation and corresponding signs and symptoms, which
include peripheral edema and jugular venous distention, and abdominal pain and nausea
(Kemp & Conte, 2012). As a result of ventricular dysfunction, individuals living with HF
experience a significant symptom burden. Studies indicate that dyspnea and fatigue are
the two most common and distressful symptoms, but also report that patients experience
insomnia, pain, depression, anxiety, cough, anorexia, dry mouth, nausea, palpitations,
dizziness, and difficulty concentrating, among others (Janssen, Spruit, Wouters, &
Schols, 2008; Zambroski, Moser, Bhat, & Ziegler, 2005).
HF Classification Systems and Models of Care
The NYHA classification system for HF is based on the occurrence of fatigue,
palpitations, dyspnea, and angina with various degrees of activity. Clinicians use this
system to assess functional abilities and mortality risk in the context of HF (Kemp &
Conte, 2012). Class I patients are asymptomatic with usual activity; class II patients are
asymptomatic at rest, but have slight limitations with usual activity due to symptoms;
class III patients have more moderate limitations that occur with less than usual activity;
and class IV patients have significant symptoms even at rest, limiting their ability to
participate in any activity (Hunt et al., 2009).
The American College of Cardiology/American Heart Association (ACC/AHA;
Hunt et al., 2001) developed a second classification system to supplement the NYHA
system. The ACC/AHA classification incorporates markers of the development and
progression of HF and outlines goals of therapy based on disease staging. This staging
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system highlights disease prevention strategies for patients at high risk for HF and
recommends a continuum of treatment options for individuals with structural heart
disease based on their symptom burden, functional limitations, and response to current
therapies. Lifestyle modifications, such as diet and exercise, largely constitute risk
reduction strategies for individuals at high risk for HF, whereas pharmacologic, device
therapy (such as biventricular pacemakers and implantable defibrillators), and surgical
options are accepted interventions for advancing HF. These guidelines recommend endof-life care when individuals meet criteria for stage D, class IV HF and are no longer
responsive to evidence-based medical or surgical therapies.
Advocates for palliative care have suggested that practitioners initiate palliative
care earlier in the trajectory of HF rather than at the end stage (Adler et al., 2009;
Bekelman, Nowels, Allen et al., 2011; Bekelman, Nowels, Retrum et al., 2011; Goodlin,
2009; Hupcey et al., 2009). More contemporary conceptualizations of palliative care
characterize it as a supportive approach that should be initiated for individuals impacted
by chronic or life-limiting illnesses, such as HF, at the time of diagnosis to improve
symptom management, quality of life, communication, decision making, and
psychosocial support for the patient and family (Adler et al., 2009; Goodlin, 2009;
Hupcey et al., 2009). Unlike traditional disease management programs, models
integrating palliative care incorporate goals of psychosocial and spiritual well-being and
aim to facilitate personal growth (National Consensus Project for Quality Palliative Care,
2009). Research examining whether individuals with HF report positive psychosocial
consequences or personal growth as a result of their illness experience is needed to
support the development of these supportive care models.
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Personal Growth
Over the last 20 years, researchers in the behavioral, psychological, social, and
health sciences have examined the concept of personal growth more extensively.
Researchers have conceptualized personal growth as positive psychosocial adjustment or
adaptation to some form of adversity, such as a serious illness. This kind of growth has
been referred to in the literature as post-traumatic growth (PTG), stress-related growth,
thriving, adversarial growth, benefit finding, and positive disease adjustment (Barskova
& Oesterreich, 2009). Corresponding assessment tools measure growth as an individual’s
ability to achieve a positive change in relationships, a greater appreciation for life, a
change in life priorities, personal strength, new opportunities, and enhanced spirituality
(Calhoun & Tedeschi, 2006; Pakenham, 2007). The literature on personal growth
suggests that growth is dependent on coping with a difficult experience (Barskova &
Oesterreich, 2009). Similarly, Tedeschi and Calhoun (2004) assert within their work on
PTG that the adverse event or stimulus should be serious enough to incite stress that is
sufficient to challenge or threaten existing personal worldviews and to provoke reframing
of life goals and priorities.
Medical researchers have most frequently studied growth in cancer (Stanton,
Bower, & Low, 2006) and HIV (Milam, 2006a) populations; other research has been
conducted with individuals living with multiple sclerosis, arthritis, lupus erythematosus,
neurological disorders, and heart disease (Barskova & Oesterreich, 2009). In a review of
studies exploring growth in individuals living with a variety of medical illnesses,
Barskova and Oesterreich (2009) concluded that demographic factors (e.g., age, gender,
and ethnicity), as well as social support, coping styles, and mental and physical health,
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correlated with measures of growth. They suggested that growth may be an important and
relevant indicator of positive disease outcomes. Subsequent positive outcomes
significantly associated with growth included improved morbidity and mortality, higher
CD4 T-lymphocyte levels, better health-related quality of life (HRQOL), and decreased
levels of cortisol, pain, fatigue, disability, depression, and anxiety (Barskova &
Oesterreich, 2009).
Another approach to growth in response to serious health conditions has been to
consider it an adaptive response to uncertainty (Mishel, 1990). Growth through
uncertainty has been studied less frequently than has PTG and mostly in cancer
populations (Mishel & Clayton, 2008). Mishel (1990) describes growth through
uncertainty, experienced by individuals living with ongoing uncertainty due to persistent
illness, as a potential outcome within her reconceptualized uncertainty in illness theory
(RUIT). In the RUIT, growth is defined as a new life perspective, that is, “a new ability
to focus on multiple alternatives, choices and possibilities; re-evaluate what is important
in life; consider variations in personal investment; and appreciate the impermanence and
fragility of life” (Mishel & Clayton, 2008, p. 60). The RUIT proposes that individuals
who achieve growth through uncertainty move beyond basic adaptation and experience a
process of favorable psychological adjustment (Mishel, 1990).
In general, studies explicitly examining either PTG or growth through uncertainty
in an HF population are lacking. The following well-documented factors characterize HF
as a challenging illness to live with: (a) an unpredictable illness course, (b) uncertainty in
prognosis, (c) significant symptom burden, and (d) impact on psychosocial well-being.
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Efforts to improve the holistic management of HF would also benefit from a greater
understanding of how these factors relate to personal growth.
Uncertainty in HF
Individuals living with HF, their caregivers, and their health care providers
frequently experience uncertainty related to knowledge deficits, an unpredictable disease
trajectory, inadequate social support, and varying frequency, duration, and severity of
symptoms and distress over time (Brännström, Forssell, & Pettersson, 2011; Falk,
Swedberg, Gaston-Johansson, & Ekman, 2007; Hopp, Thornton, & Martin, 2010;
Hupcey, Fenstermacher, Kitko, & Penrod, 2010; Jurgens, 2006). In a qualitative review
of individuals’ experiences of living with HF, Yu, Lee, Kwong, Thompson, and Woo
(2007) reported that
patients used the terms “a roller coaster life” and “knocking on death’s door” to
describe their meanings of living with CHF [congestive heart failure]. The former,
a symbolic representation of the life situation characterized by the ongoing
oscillations between ups and downs, the latter of being threatened by the
unpredictable condition and uncertain future. (p. 478)
Thus, uncertainty contributes to the challenges of coping with HF. Overcoming or
adapting to uncertainty is likely to be a prerequisite for growth following a diagnosis of
HF. Therefore, in this study, the RUIT served as an overall conceptual framework for the
exploration of personal growth in individuals living with HF.

9
Conceptual Frameworks
Mishel’s (1990) RUIT served as the primary guiding framework for this study. In
addition to the RUIT, Tedeschi and Calhoun’s (2004) conceptualization of PTG and
assumptions related to PTG also informed the development of this study.
Reconceptualized Uncertainty in Illness Theory
The RUIT describes how individuals living with chronic illness or disease
reoccurrence can reappraise ongoing uncertainty and move beyond adaptation to achieve
growth through the discovery of new life meaning and the acceptance of change (Mishel,
1990; see Appendix A). Uncertainty is among the challenges experienced by individuals
living with HF. The RUIT provides a broad lens to examine whether individuals can
potentially achieve growth through attempts to cope with this type of adversity. It was
developed in response to clinical cases and qualitative studies of uncertainty in chronic
illness in which Mishel’s (1988) original uncertainty in illness theory (UIT) did not
account adequately for the experiences of some individuals living with enduring
uncertainty.
Mishel’s (1990) reconceptualization of the UIT was influenced by critical social
theory and a desire to situate uncertainty in the context of culture. Critical social theory
illuminated Western biases that tend to value order, balance, and predictability over
uncertainty and disequilibrium, potentially limiting growth and change (Mishel, 1990).
Furthermore, UIT was mechanistic in nature, focusing more on uncertainty as a state than
as a process. In addition, the UIT did not address how time and culture could influence
one’s experience of uncertainty over the course of chronic illness (Mishel, 1990). The
RUIT has the following new assumptions (Mishel, 1990):
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• Uncertainty in chronic illness is an ongoing experience.
• Appraisal of uncertainty evolves over time.
• Embracing complexity and change alters existing personal realities and may
help individuals to adapt and grow in the face of uncertainty.
Mishel (1990) retained the original antecedents of UIT (stimuli frame, cognitive
capacity, and structure providers), which classify the factors that can contribute to
uncertainty (see Appendix B). Stimuli frame includes symptom pattern, event familiarity,
and event congruence. The stimuli frame can, in turn, be influenced by the other two
antecedents, cognitive capacity and structure providers. Structure providers consist of
credible authority, social support, and education.
The RUIT builds upon uncertainty, originally defined as “the inability to
determine the meaning of illness-related events occurring when the decision maker is
unable to assign definite value to objects or events and/or is unable to accurately predict
outcomes” (Mishel & Clayton, 2008, p. 59), by suggesting that individuals can integrate
ongoing uncertainty into a novel worldview not characterized by predictability and
control and, as a result, achieve growth. Reframing one’s view of uncertainty begins at
the appraisal stage and is influenced by two new concepts, self-organization and
probabilistic thinking (Mishel & Clayton, 2008).
Self-organization is defined as the ability of an individual to recreate a new
version of order from enduring uncertainty that is built on probabilistic or conditional
thinking (Mishel, 1990). Probabilistic thinking implies that uncertainty becomes an
accepted part of one’s reality, generating new possibilities and is conceptualized in the
RUIT as an opportunity for growth (Mishel, 1990). Additionally, prior life experiences,
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physiologic status, social resources, and interactions with health care providers can
influence this process. Social support and health care providers that promote probabilistic
thinking can help facilitate growth (Mishel, 1990). Therefore, appraisal of uncertainty in
the RUIT is based on one’s ability to cognitively reframe an event in a positive yet
realistic way.
Post-Traumatic Growth
Tedeschi and Calhoun (2004) conceptualize PTG as a process and/or an outcome
that results from grappling with a life-altering event, commonly characterized as a
trauma, major crisis, threat, or significant challenge. The following assumptions guide
Tedeschi and Calhoun’s (2004) work on PTG:
• PTG occurs in circumstances in which an individual’s fundamental worldviews
are substantially disrupted as a result of an extremely adverse event that may be
discrete or ongoing.
• Growth occurs concurrently with serious psychological distress and does not
necessarily minimize the suffering associated with a traumatic event or imply that
an individual, if given the option, would choose to experience the challenging
circumstances.
• Growth does not simply reflect a coping mechanism, but rather, an outcome or
process that enables an individual to move beyond pre-trauma levels of
adaptation, which is characterized by some degree of personal transformation.
• Growth is dependent on an individual’s struggle to come to terms with a reality
that has been significantly altered by the challenging circumstances.
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• The struggle primarily represents a process of cognitive restructuring, but it also
encompasses an affective component.
Specific Aims
The specific aims of this study were:
1. To describe the levels of personal growth in adults living with NYHA class IIIV HF and explore the relationship of personal growth with age, sex,
ethnicity, disease severity, time since diagnosis, symptom status, and
uncertainty levels.
2. To determine the extent to which variance in personal growth in individuals
living with NYHA class II-IV is accounted for by age, sex, ethnicity, disease
severity, time since diagnosis, symptom status, and uncertainty.
The following research questions address these specific aims:
1. Do adults living with NYHA class II-IV HF report personal growth following
their diagnosis of HF?
2. To what extent are age, sex, ethnicity, disease severity, time since diagnosis,
symptom status, and uncertainty levels associated with personal growth in
individuals with HF?
3. Which variables (age, sex, ethnicity, disease severity, time since diagnosis,
symptom status, and uncertainty levels) make independent contributions to
personal growth in individuals living with NYHA class II-IV HF?
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Limitations
The following limitations of this study were anticipated:
1. Convenience sampling was used to recruit participants, reducing the external
validity of findings and decreasing generalizability.
2. Participants living near San Antonio, TX, were recruited, limiting the
generalizability of findings to individuals with HF with similar socioeconomic
and demographic characteristics.
3. Participants were limited to those who could speak and understand English,
most likely limiting conclusions related to ethnic differences in personal
growth.
4. The descriptive, exploratory nature of the study design did not allow for the
testing of causal hypotheses between select variables and personal growth.
5. Cross-sectional data did not support inferences related to growth as an
evolving temporal process.
Significance of the Study
Results from this study addressed significant gaps in the literature by first
revealing the extent to which personal growth is present in persons with HF and by
identifying factors that are associated with growth. Findings add to the body of literature
exploring growth in chronic illness and enhance the theoretical understanding of growth
through uncertainty. Findings may also help inform the supportive care models being
developed to supplement traditional medical management of HF.
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CHAPTER 2
REVIEW OF THE LITERATURE

In this chapter, a summary of the literature on personal and post-traumatic growth
in cardiac populations and how these findings compare with findings of personal and
post-traumatic growth in other illnesses is provided. Next, uncertainty in HF, which is
postulated under the RUIT as a stimulus for growth, is presented, and the literature that
explores the concept of growth through uncertainty is described. The chapter concludes
with a summary of symptom status and burden in HF.
Personal Growth: An Overview
In recent years, there has been increasing interest in the potential positive
psychosocial consequences of illness rather than focusing exclusively on negative
outcomes (Barskova & Oesterreich, 2009). This trend has been particularly evident in
health psychology (Affleck, Tennen, Croog, & Levine, 1987; Barskova & Oesterreich,
2009; Chan, Lai, & Wong, 2006; Leung et al., 2010; Luszczynska, Sarkar, & Knoll,
2007; Petrie, Buick, Weinman, & Booth, 1999; Senol-Durak & Ayvasik, 2010a, 2010b;
Sheikh, 2004) and nursing (Benetato, 2011; Black & Sandelowski, 2010; Chiba,
Kawakami, & Miyamoto, 2011; Kahana, Kahana, Deimling, Sterns, & VanGunten, 2011;
Kamibeppu et al., 2010; Mosher, Danoff-Burg, & Brunker, 2006; Panagopoulou,
Triantafyllou, Mitziori, & Benos, 2009; Rahmani et al., 2012; Sato, Yamazaki, & Sakita,
& Bryce, 2008; Steel, Gamblin, & Carr, 2008; Turner & Cox, 2004; Turner-Sack, Menna,
& Setchell, 2012).
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Researchers focusing on personal growth have attempted to identify its
antecedents, understand relationships among factors that contribute to or impede growth,
and evaluate the influence of growth on other clinically important outcomes, such as
mortality, depression, and health behaviors, in a variety of populations with chronic or
acute health problems. Personal growth has been most extensively studied in cancer
populations. Researchers have also studied personal growth in individuals living with
HIV, multiple sclerosis, arthritis, lupus, neurological disorders, and heart disease
(Barskova & Oesterreich, 2009). In addition to illness, researchers have studied growth in
a variety of traumatic contexts, including grief, infertility, sexual abuse, domestic
violence, traumatic injuries, homicides, war, natural disasters, and airline crashes (Antoni
et al., 2001; Tedeschi & Calhoun, 2004).
The growth literature encompasses seminal research in psychology that explored
individuals’ abilities to successfully adapt, positively perceive difficult circumstances, or
find meaning during times of significant stress, loss, or suffering. It has been largely
influenced by well-known scholars, such as Maslow, Caplan, Dohrenwend, Frankl, and
Yalom, who have generated foundational research and theory pertaining to stress, coping,
and positive psychology (Tedeschi & Calhoun, 2004). Beginning in the 1980s,
researchers began studying growth as a distinct phenomenon that was conceptualized as a
process or outcome characterized by positive changes in psychosocial perceptions
resulting from significant adversity (Tedeschi & Calhoun, 2004). To support this inquiry,
researchers have used a variety of psychometric instruments to measure personal or posttraumatic growth, including the Stress-Related Growth Scale (SRGS; Park, Cohen, &
Murch, 1996), the Benefit Finding Scale (BFS; Mohr et al., 1999), the Posttraumatic
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Growth Inventory (PTGI; Tedeschi & Calhoun, 1996), and the Growth Through
Uncertainty Scale (GTUS; Mishel & Fleury, 1994).
Tedeschi and Calhoun’s (2004) work on PTG and studies using the PTGI have
informed much of the research on personal growth. Tedeschi and Calhoun (2004) define
trauma as more or less synonymous with highly stressful life events or crisis, including
but not restricted to physical or psychological injury. They suggest that PTG can occur
with “circumstances that represent significant challenges to the adaptive resources of the
individual, and that represent significant challenges to individuals’ ways of understanding
the world and their place in it” (Janoff-Bulman, as cited in Tedeschi & Calhoun, 2004, p.
1). Tedeschi and Calhoun (2004) conceptualize PTG as encompassing processes of
cognitive reappraisal as well as cognitive and behavioral outcomes of those processes.
Personal or Post-Traumatic Growth in Cardiac Populations
Relatively few studies explore personal growth in cardiac conditions. Most
studies were exploratory. For purposes of this review, they are presented chronologically.
Affleck et al. (1987) conducted a secondary analysis of data from the Boston Heart
Patient Study, a longitudinal investigation of health, psychological outcomes, and social
outcomes in healthy men who had experienced a first-time MI. They found that
individuals who reported benefits 7 weeks after experiencing their first MI were less
likely to have a subsequent MI and had experienced less morbidity over the following 8
years than those who reported no benefits. Both 7 weeks and 8 years following the initial
MI, a majority (58% and 59%, respectively) reported benefits or gains that they attributed
to the event. Gains or benefits included learning the value of healthier behaviors and
positive changes in life, values, overall outlook, or relationships.
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Participants in the original study (N = 345) were recruited from 26 hospitals in
Massachusetts. Interviews were conducted after discharge home, 7 weeks following a
first MI. Approximately 60% (n = 205) were reinterviewed 8 years later. In the original
and follow-up interviews, causal attributions (categorized as personal behavior, stress
responses, other people, bad luck, and hereditary) and perceived benefits (in response to
open-ended questioning) were among the topics assessed. The most frequently reported
benefits involved changes in (a) life philosophy/values/religion, (b) family life and
relationships, (c) stress and conflict reduction, (d) life enjoyment, (e) health behaviors,
and (f) longevity expectations.
The secondary analysis (N = 287) included a sample of 82 participants who died
before the 8-year follow-up plus all 205 who were interviewed again at 8 years. Among
those interviewed for the 8-year follow-up, 111 had suffered at least one additional MI
(Affleck et al., 1987). After controlling for age, prognostic severity of the initial MI, and
socioeconomic status, the inability to identify benefits and blaming others (e.g., family
problems) 7 weeks after the initial MI were independent predictors of a second MI over
the subsequent 8 years. Among the 205 survivors interviewed 8 years after the initial MI,
after controlling for age, statistically significant independent predictors of greater
morbidity 8 years later included the prognostic severity of the initial MI, socioeconomic
status, inability to identify benefits and causal attributions of stress 7 weeks after the
initial MI. Affleck et al. (1987) also found that participants who experienced a second MI
prior to the 8-year follow-up reported greater benefit at 8 years than did those who had
not. Affleck et al. (1987) acknowledged that the identification of benefits by the sample
studied may not generalize to sicker populations for which clinical outcomes may not be
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as responsive to lifestyle changes or emotional reframing. This study was the first to
explore associations between perceiving benefits, a key component within the personal
growth literature, and health outcomes in a cardiac population. A major limitation was
the all-male sample.
Petrie et al. (1999) examined the positive changes reported by individuals 3
months after either their first MI or a diagnosis of breast cancer. The MI sample consisted
of 143 participants (87% men), aged 65 years or younger (mean age ≈ 53 years). The
breast cancer sample consisted of 52 women with primary breast cancer (and no prior
breast cancer diagnosis), who were scheduled to begin radiation therapy (mean age ≈ 54
years). Both samples were recruited from university hospitals in New Zealand. At 3
months, 58% of both samples completed a questionnaire that asked “What positive
effects do you feel may have occurred in your life due to your heart attack/cancer?”
(Petrie et al., 1999, p. 539) There were no significant differences in illness severity
between participants who reported positive changes from their illness and those who did
not in either the MI or breast cancer group. However, patients who experienced an MI
were significantly more likely to report positive outcomes than were participants in the
breast cancer group.
Three independent researchers reviewed and categorized the written responses
detailing the participants’ positive effects of illness. Positive outcomes reported by the
MI participants included (a) healthy lifestyle changes (68%), (b) greater appreciation of
health and life (28%), (c) improved close relationships (23%), and (d) changes in
personal life priorities (17%); followed by smaller percentages of participants reporting
perceiving second chances, greater knowledge about health, and improved empathy.
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Breast cancer participants reported improved close relationships (33%), greater
appreciation of life (27%), changes in personal priorities (20%), and improved empathy
(20%). No significant differences related to gender were shown in the MI group, and no
significant relationships among positive outcomes and age, education, self-rated health,
and life satisfaction were shown in either group (Petrie et al., 1999).
Sheikh (2004) examined the degree to which personality traits, coping styles, and
social support contributed to positive outcomes in survivors of cardiac arrest. The sample
consisted of 28 participants recruited from a cardiac rehabilitation program in the United
States and 82 participants recruited from a cardiac support group in the United Kingdom.
Positive outcomes were measured using the PTGI total score. In addition to assessing
demographics, time since diagnosis, treatments, and perception of control, participants
completed measures of personality traits, social support, stressful life events, and coping.
No significant differences between the samples were shown in any of the main
study variables. PTG was positively correlated with measures of problem-focused and
emotion-focused coping to a moderate degree and more weakly with extraversion and
satisfaction with social support. No significant association was found between time since
diagnosis and PTG, suggesting that time alone is not a sufficient condition for growth.
There was a significant association between PTG and perceived control. Extraversion
was the only personality trait independently predicting PTG. Controlling for previous
traumatic experiences and perceived control, extraversion was the strongest predictor of
PTG; problem-focused coping partially mediated that association (Sheikh, 2004). Social
support satisfaction was not found to be a significant independent predictor of PTG.
Sheikh (2004) hypothesized that resources that facilitate the cognitive processing of an
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event may be more important to achieving growth than the overall satisfaction with social
support or the number of people available to help.
Chan et al. (2006) studied the effects of personal resilience and cardiac
rehabilitation on PTG in 67 Chinese patients with single-vessel CAD following
percutaneous transluminal coronary angioplasty (PTCA). They found that resilience and
attributions of growth to the rehabilitation program were significant predictors of PTG. A
path model showed strong direct effects of both resilience and attributions of growth to
participation in cardiac rehabilitation. In addition, there was a weaker, although still
significant, indirect path whereby the attributions of growth to participation in
rehabilitation partially mediated the relationship between resilience and PTG.
Resilience in this study was evaluated using a composite score from measures of
optimism, perceived control, and self-esteem. PTG was measured using a composite of
items from the SRGS and the PTGI. Most of the participants reported not having a
religion. Participants reported higher levels of PTG in the area of family appreciation and
lower levels of PTG related to spirituality. The authors suggested that study findings
imply that certain personal attributes, such as resilience, may help facilitate an
individual’s ability to perceive gain in other areas of his or her life, in the face of serious
stress or suffering that result from illness.
Panagopoulou et al. (2009) conducted semistructured interviews with 11 married
couples in Greece to explore dyadic benefit finding. One partner in each couple had
experienced an MI. Interview questions focused on general concerns and the
consequences and positive outcomes of experiencing an MI. Specifically, participants
were asked the following question, which has been utilized in other studies exploring
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benefit finding: “Sometimes people who are faced with a sudden health threat find some
positive aspect in the experience. For example, some people feel they learn something
about themselves or others. Have you found anything positive in this experience?”
(Panagopoulou et al., 2009, p. 293)? Three researchers analyzed the interview transcripts
using an interpretative phenomenologic approach. Participants perceived the MI as a
stimulus for change, particularly in terms of health behaviors and as a chance to help
others. Spouses were more purposeful in their efforts to recognize benefits, but had a
more difficult time perceiving positive consequences from their partners’ MI. In most
cases, spouses acknowledged benefits only in terms of having avoided more serious
outcomes. Patients and spouses reported that benefit finding was generally a deliberate
effort.
Leung et al. (2010) investigated PTG in patients with CAD (N = 1,237) enrolled
in outpatient rehabilitation in Canada. This study was the only one found that included
participants with a diagnosis of HF (N = 178). This secondary analysis of data from a
prospective cohort study (Grace et al., 2008) explored the relationships among
sociodemographic, clinical, and behavioral factors and PTGI scores. Leung et al.
examined which factors contributed most significantly to PTG and they compared scores
of PTG from their cardiac sample with PTGI scores reported in the literature for other
chronic illnesses.
Significant correlates of PTG included younger age, non-White race, less income,
reduced functional abilities, less depression, and better social support. In addition,
participants who perceived their CAD as an acute illness associated with serious
outcomes and as a condition that was responsive to treatment, rather than a chronic
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cyclical disease in which they had less control over outcomes, reported higher levels of
PTG. In general, compared with results of earlier studies in patients with various
diagnoses, PTG scores in this large heterogeneous sample of cardiology outpatients were
equivalent to previously reported scores in patients with MI or CABG, HIV/AIDS, and
colorectal or prostate cancers, but substantially lower than previously reported in patients
with multiple sclerosis, breast cancer, stage IV liver cancer, or bone marrow transplant.
Senol-Durak and Ayvasik (2010a, 2010b) explored factors associated with PTG
among patients with MI and spouses of patients with MI. The MI sample consisted of 148
individuals (mean age = 56 years; 87% male) following an MI, recruited from four
different Turkish hospitals (Senol-Durak & Ayvasik, 2010a). Senol-Durak and Ayvasik
(2010a) investigated the influence of perceived social support, event perception, and
coping on PTG in this sample. Turkish translations of the PTGI and measures of coping
and social support were used. Overall, women had significantly higher PTG scores than
did men. PTG scores were significantly and positively correlated with measures of social
support, emotion-focused coping, and problem-focused coping.
In a structural equation model, perceived social support was significantly and
directly associated with event perception and coping. Coping (problem-focused, emotionfocused, and indirect) was significantly related to PTG; perceived social support showed
significant indirect effects via coping on PTG (Senol-Durak & Ayvasik, 2010a).
However, event perception was not significantly related to PTG. The authors suggested
that variations in the nature of an illness (disease stage, symptom burden, illness duration,
and probability of reoccurrence) may impact results related to event perception and
therefore its impact on PTG.
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Synthesis of Findings
In summary, researchers examining personal growth in cardiac populations have
included individuals who experienced an MI (Affleck et al., 1987; Leung et al., 2010;
Panagopoulou et al., 2009; Petrie et al., 1999; Senol-Durak & Ayvasik, 2010a), with a
history of heart disease, specifically cardiac arrest (Sheikh, 2004), with single-vessel
CAD undergoing PTCA (Chan et al., 2006), and with either a diagnosis of HF or history
of CABG (Leung et al., 2010). Variations in population characteristics and measurement
approaches limit the ability to draw solid conclusions related to personal growth in
cardiac populations.
All of the quantitative studies were observational; only two included participants
from the United States (Affleck et al., 1987; Sheikh, 2004). Only one study included
patients with a diagnosis of HF (Leung et al., 2010). Most studies involved crosssectional data collection; only two studies evaluated the trajectory of growth over time,
but with samples that were exclusively (Affleck et al., 1987) or predominantly (Petrie et
al., 1999) male.
Growth was explored in relation to MI reoccurrence and morbidity (Affleck, et
al., 1987); disease severity (Petrie et al., 1999); time since diagnosis (Sheikh, 2004);
gender, age, and other illness populations (Leung et al., 2010; Petrie et al., 1999);
ethnicity, income, functional abilities, and depression (Leung et al., 2010); personality
traits (Sheikh, 2004); event perceptions (Leung et al., 2010; Senol-Durak & Ayvasik,
2010a; Sheikh, 2004); social support (Leung et al., 2010; Sheikh, 2004); coping (SenolDurak & Ayvasik, 2010a; Sheikh, 2004); resilience (Chan et al., 2006); and causal

24
attributions or perceived benefits (Affleck et al., 1987; Chan et al., 2006; Panagopoulou
et al., 2009; Petrie et al., 1999).
In general, benefits or positive outcomes reported by the participants fit into the
following categories: (a) health promotion knowledge/strategies (Affleck et al., 1987;
Panagopoulou et al., 2009; Petrie et al., 1999); (b) reevaluation of values, priorities, and
interpersonal relationships (Affleck et al., 1987; Chan et al., 2006; Panagopoulou et al.,
2009; Petrie et al., 1999); (c) greater appreciation for life (Affleck et al., 1987; Petrie et
al., 1999); and enhanced religious or spiritual views (Affleck et al., 1987; Chan et al.,
2006; Panagopoulou et al., 2009).
Personal or Post-Traumatic Growth in Other Illness Populations
Barskova and Oesterreich (2009) conducted a systematic review of 68 studies
published between 1985 and 2009 that focused on growth in patients with or survivors of
a variety of medical illnesses, including cancer (36 studies), HIV/AIDS (eight studies);
brain and spinal cord injuries (six studies); heart disease (five studies); multiple sclerosis
(four studies); rheumatoid arthritis (four studies); multiple chronic conditions or
disabilities (two studies); burns (one study); orthopedic injuries (one study); and lupus
erythematosus (one study). A majority of these studies measured personal growth using
either the PTGI or the Benefit Finding Scale (BFS).
In two studies that used the PTGI, higher levels of growth were found in
participants who were younger in age or female (Bellizzi, 2004; Morris, ShakespeareFinch, & Scott, 2007). In contrast, studies using the BFS either did not detect
relationships with age or sex (Katz, Flasher, Cacciapaglia, & Nelson, 2001; Schulz &
Mohamed, 2004; Siegel & Schrimshaw, 2007) or found greater growth in older compared
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with younger participants (Carver & Antoni, 2004; Luszczynska et al., 2007).
Correlations between growth and education or income level examined in studies included
in Barskova and Oesterreich’s (2009) review were predominantly nonsignificant. Five
studies that examined growth in relation to ethnicity demonstrated that compared with
non-Hispanic White participants, minority groups, specifically African Americans and
Hispanics, reported more personal growth (Milam, 2004, 2006b; Siegel, Schrimshaw, &
Pretter, 2005; Tomich & Helgeson, 2004; Urcuyo, Boyers, Carver, & Antonio, 2005).
Two studies that did not show a significant association between growth and ethnicity
(Thornton & Perez, 2006; Widows, Jacobsen, Booth-Jones, & Fields, 2005) included a
small number of ethnically diverse participants, possibly diminishing the statistical power
to detect significant relationships.
Six studies cited by Barskova and Oesterreich (2009) showed that growth was
significantly higher in individuals who had lived longer with their diagnosis (Cordova,
Cunningham, Carlson, & Andrykowsky, 2001; Evers et al., 2001; McGrath & Linley,
2006; Pakenham, 2005; Powell, Ekin-Wood, & Collin, 2007; Sears, Stanton, & DanoffBurg, 2003), whereas only one (Milam, 2004) found a negative association between time
since diagnosis and PTG in individuals living with HIV. Nine studies cited by Barskova
and Oesterreich did not detect a significant relationship between time and growth.
Illness severity (based on established criteria for specific diseases) was related to
growth in some studies cited by Barskova and Oesterreich (2009), but not others. In three
studies of cancer, greater personal growth was found in individuals with more advanced
disease (Carver & Antoni, 2004; Tomich & Hegelson, 2004; Urcuyo et al., 2005), but
Lechner et al. (2003) found higher levels of PTG in people with stage II cancer compared
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with either stage I or stage IV. One study of multiple sclerosis showed higher growth in
participants in a relapse-remitting phase than among those living with a chronic,
progressive form of the disease (Pakenham, 2005). Six studies cited by Barskova and
Oesterreich did not demonstrate significant associations between growth and illness
severity.
Uncertainty in HF
Uncertainty is a common challenge for persons living with HF (Hopp et al., 2010;
Jurgens, 2006; Waterworth & Jorgensen, 2010; Winters, 1999; Yu et al., 2007). Winters
(1999) conducted one of the first studies to examine uncertainty in community-residing
patients with HF. The sample in this mixed-methods study included 15 men and 7 women
classified as NYHA class I to IV who were recruited from outpatient cardiology clinics.
The mean number of years that participants had been living with HF was 7 (range, 1 to 21
years). Participants most frequently described uncertainty related to (a) changing
symptoms and therapies, (b) insufficient patient education, (c) decreased perceived
control, (e) thoughts of the future, and (f) the impact of aging. In addition, participants
reported higher uncertainty at the time of initial diagnosis and during diagnostic testing
and treatment adjustments. Themes characterizing uncertainty in the qualitative portion
of this study included recognition and response to symptoms and treatment, trying to stay
well: a shared responsibility, and looking forward: quality of life and death (Winters,
1999). Participants’ perceptions of uncertainty changed over time and were influenced by
the adequacy of information, communication, trusting relationships with providers,
spirituality, hope, social support, and self-care capabilities. Uncertainty scores (possible
range, 23-115) were moderate (mean score = 54.9, SD = 7.7). Scores were highest for the
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items that addressed uncertainty related to the progression of symptoms, expectations
related to the future, and the likelihood of additional health problems (Winters, 1999).
Qualitative Studies
Several exclusively qualitative studies have identified uncertainty as a common
theme among individuals living with HF (Aldred, Gott, & Gariballa, 2005; Brännström,
Ekman, Boman, & Strandberg, 2007; Brännström, Ekman, Norberg, Boman, &
Strandberg, 2006; Dougherty, Pyper, Au, Levy, & Sullivan, 2007; Nordgren, Asp, &
Fagerberg, 2007; Russell, Geraci, Hooper, Shull, & Gregroy, 1998; Waterworth &
Jorgensen, 2010).
Russell et al. (1998) explored how individuals living with HF or chronic
obstructive pulmonary disease (COPD) understood or explained the etiology, cause,
effects, and treatments of an acute exacerbation. Participants were recruited from a
Veterans Affairs Medical Center. The HF subsample consisted of 30 adult men (mean
age = 69 years; mean ejection fraction = 35%) admitted to noncritical care units. The
participants’ mean subjective disease severity was 3.2 on a 1-to-4 scale, with 4 indicating
more severe disease. Participants reported uncertainty related to the cause of their
hospitalization. In particular, one third of the HF participants could not describe the
factors that had triggered an acute change in their HF stability, precipitating the need for
hospitalization.
Brännström et al. (2006) conducted a phenomenological study to better
understand the experience of living with severe HF. Participants included 1 woman
(NYHA class III) and 3 men (NYHA class IV) receiving palliative advanced home care
in Sweden, with a median age of 79 years. One-time interviews were conducted in the
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individuals’ homes. Using a hermeneutic interpretative approach to analysis, Brännström
et al. identified four major themes, two of which were related to uncertainty: “being
aware that one’s life hangs by a fine thread” and “struggling to cope with one’s
unpredictable deteriorated body” (Brännström et al., 2006, p. 297). Uncertainty was
described in relation to symptoms, periods of instability, and expected death. Two other
themes pertained to isolation and the reactions to receiving HF care at home. Brännström
et al. (2006) characterized the overall experience of living with severe HF as “being
forced to ride a ‘roller coaster’ with an ongoing oscillation between ups and downs” (p.
301). To further elucidate the meaning of living with the ups and downs, Brännström et
al. (2007) subsequently recruited 1 of those participants with severe HF(NYHA class IV)
and his wife, who were living at home, to participate in longitudinal interviews every 3 to
5 months over a 4.5-year period, for a total of 26 interviews. Using a phenomenological–
hermeneutic approach, Brännström et al. (2007) characterized the participants’ overall
experience of ups and downs as “integrating the unpredictable illness into life, enduring
suffering, and enjoying life.” Subthemes included “Living life as it has become; Adapting
to versus struggling against fatigue; Learning to take the good with the bad—striving to
keep a check on the failing heart; [and] Finding meaning in togetherness with the spouse,
others and God” (Brännström et al. 2007, p. 14). These themes characterized the couple’s
daily attempts to balance the uncertainty associated with living with a diagnosis of HF,
while embracing opportunities to live more fully.
Aldred et al. (2005) studied the impact of advanced HF on 7 men and 3 women,
recruited from a U.K. hospital, aged 60 years or older, categorized as NYHA class II to
IV, and their primary informal caregivers. Interviews addressed the participants’
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understanding of HF, its impact of their daily lives, their educational needs, their feelings
on available support services, and their general concerns. The patients and their
respective caregivers were interviewed together in their homes. They identified four
major themes: impact of HF on daily life, impact of HF on relationships, professional
support, and future concerns. Uncertainty per se was not identified as a theme in this
study, but participants expressed concerns about the unpredictability of symptoms
making it difficult to plan daily activities. Participants also had concerns about prognosis,
changes in condition, and availability of support services.
Dougherty et al. (2007) conducted semistructured interviews with 24 participants
(21 male) meeting criteria for stage C or D HF (Heart Failure Society of America, 2010a,
2010b) to explore how individuals living with advanced HF perceive and plan for their
future. This qualitative study was part of a larger study that aimed to explore end-of-life
decision making in people living with advanced HF or COPD. Using grounded theory
content analysis procedures, the authors identified Living with HF as the central theme
and the following subthemes: my experience of HF, help with HF, and my future with HF.
Uncertainty was implicit in the participants’ characterizations of daily life, their ability to
make plans, end-of-life discussions with family, and life expectancy: “people with HF
described their future in terms of an uncertain shortened life” (Dougherty et al., 2007, p.
483, emphasis original).
Nordgren et al. (2007) conducted a phenomenological study with 4 men and 3
women, 38 to 66 years of age, to explore their experiences of living with HF. Participants
were recruited from a hospital in Sweden. All reported at least one hospital admission for
HF within the past year and met criteria for NYHA class III or IV. The major themes
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included ambiguity of the body, losing track of life, and balancing life. Uncertainty was
implicit in these themes; overall, Nordgren et al. concluded that living with HF was
experienced “as living with an unpredictable and failing body, an altered self-image, a
rapidly changing health condition, and a life under constant and immediate threat” (p. 6).
However, over time, individuals adjusted to living within their limitations, participated in
activities that were meaningful to them, and achieved a sense of balance and contentment
in their lives.
Waterworth and Jorgensen (2010) conducted a longitudinal, qualitative study of
25 older individuals (70 to 90 years of age) living in New Zealand who were transitioning
toward greater dependence due to their HF diagnosis. Interviews were conducted every 3
months for up to 1 year; 19 participants completed all interviews. Uncertainty emerged as
a major theme in this study. Participants expressed uncertainty about daily happenings,
future expectations, their ability to recognize changes in their health status, and death.
Information-seeking, relying on religious and community support services, following
medical instructions (e.g., regarding diet, activity, and stress management), and
participating in advanced care planning discussions with family were among the ways
participants managed uncertainty.
Bekelman, Nowels, Retrum et al. (2011) conducted interviews with 33 individuals
diagnosed with NYHA class II-IV HF and 20 informal caregivers to gain a better
understanding of palliative care needs. Participants were recruited through providers at a
university hospital in Colorado. They found that the patients’ daily and longer-term
experiences were characterized by uncertainty related to symptoms, functioning, acute
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exacerbations, and impending death. They concluded that research exploring palliative
models for this population should address the management of illness uncertainty.
Quantitative Studies
As part of a larger Swedish study, Ekman, Norberg, and Lundman (2000)
conducted an intervention study that consisted of scheduled visits to a nurse-managed
outpatient HF clinic and regular follow-up phone consultations with a group of 158
individuals diagnosed with moderate to severe HF (NYHA class III-IV). The intervention
aimed to educate participants and, when present, their caregivers on identifying and
managing HF signs, symptoms, and treatments and to provide them with tools to achieve
these goals. The nurses individualized care based on each patient’s unique illness
experience and cultural preferences. Seventy-nine participants were randomly assigned to
either the control group (conventional care) or the intervention group. A validated
Swedish version of the Cardiac Population Scale (CPS; Mishel, 1983), a modified version
of the Mishel Uncertainty in Illness Scale (MUIS), also developed by Mishel to assess
perceptions related specifically to illness ambiguity and complexity of treatments in
people with heart disease, was used to measure uncertainty. Data were collected at
baseline (during hospitalization) and 6 months later. At the 6-month follow-up, 21
participants had died, leaving 58 participants in the intervention group and 62 in the
control group. Follow-up questionnaires assessing uncertainty were completed by 45
participants in the intervention group and 47 participants in the control group.
There were no significant differences in uncertainty scores between the groups at
baseline or at follow-up. Uncertainty scores at follow-up were significantly lower for
both groups compared with baseline scores. In particular, no differences in participants’
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abilities to identify signs or symptoms of worsening HF were detected between groups at
6 months. Ekman et al. (2000) offered two possible explanations for these findings: the
CPS may not be sensitive enough to capture changes in uncertainty scores and/or the
uncertainty associated with a life-threatening illness, such as HF, might not be responsive
to cognitive strategies alone. They also suggested that measuring the participants’
knowledge post-intervention may have been a more suitable outcome for assessing the
effectiveness of the intervention (Ekman et al., 2000).
Thompson (2006) tested a model of self-care in 100 men and women with class I
or II HF to better understand the relationships among social support, spiritual well-being,
uncertainty, and self-care in this population. Path analyses were conducted to examine
social support and spiritual well-being as predictors of self-care and uncertainty, and
social support, spiritual well-being, and uncertainty as predictors of self-care, while
controlling for comorbidities. In addition, Thompson examined whether uncertainty
mediated relationships between social support and self-care and between spiritual wellbeing and self-care. Spiritual well-being was found to be the main predictor of self-care.
Thompson found strong relationships between spirituality and self-care and between
spirituality and uncertainty. Although spirituality accounted for 22% of the variance in
uncertainty, uncertainty did not significantly contribute to self-care and it weakened the
relationship between social support and self-care.
Jurgens (2006) investigated relationships among uncertainty, somatic awareness,
symptom severity, symptom pattern (sudden vs. gradual onset), age, sex, HF history, and
delay in care-seeking patterns in a sample of 201 adult patients admitted with a diagnosis
of acute HF to either an urban or suburban tertiary or community hospital in the eastern
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United States. The majority of the participants were White (95%) and male (56%), and
the mean age of the sample was 70 years. Uncertainty was measured using the MUIS–
Community Version (MUIS-C). The Heart Failure Somatic Awareness Scale (HFSAS)
was used to measure somatic awareness and symptom severity. Symptom duration was
used to measure delay in care-seeking and was assessed during a researcher interview.
Uncertainty scores (possible range, 23-115) were moderate (mean score = 71.4, SD =
9.6). Jurgens reported that the majority of the participants indicated that they still had
many questions and were not sure what was wrong with them (cf. Winters, 1999).
Uncertainty scores did not differ based on symptom onset (gradual or acute), age, sex, or
prior HF admissions. Uncertainty scores were not related to age, symptom pattern or
duration, or delay in care seeking. Uncertainty scores were positively associated HFSAS
scores (r = .36, p < .01), suggesting that greater somatic awareness and symptom severity
were associated with greater uncertainty.
Falk et al. (2007) examined the impact of uncertainty and sense of coherence on
fatigue in 93 individuals with HF (52% male; mean age = 74 years; NYHA class I-IV
HF) admitted to a university hospital in Sweden for worsening HF. To measure
uncertainty, they used a Swedish version of the CPS. To measure fatigue, they used a
Swedish version of the Multidimensional Fatigue Inventory, which measures general
fatigue, physical fatigue/tiredness, functional/activity status, motivation, and mental
fatigue. Uncertainty was positively associated with tiredness and reduced
functional/activity status. When modeled with sense of coherence and NYHA class,
uncertainty made a significant, but small (4%), independent contribution to physical

34
fatigue, but did not account for significant variance in any of the other domains of
fatigue.
Synthesis of Findings
In summary, qualitative investigations have highlighted uncertainty as a highly
challenging but common component of the HF illness experience. Consistent with the
aims of qualitative research, these studies used convenience, purposive, or theoretical
sampling procedures and included small sample sizes (2 to 33 participants). Two studies
(Bekelman, Nowels, Retrum et al., 2011; Brännström et al., 2007) included caregivers in
addition to individuals living with HF. Quantitative studies used larger sample sizes (93
to 201 participants), but also used convenience sampling. The majority of samples
included a greater percentage of men, individuals older than age 65, and participants with
NYHA class II-IV HF. Nordgren et al.’s (2007) study was the only one to specifically
examine the HF experience in a middle-aged population, but their sample only included 7
people. Only one study included African American participants (Russell et al., 1998).
Studies addressing uncertainty in HF were conducted in the United States (Bekelman,
Nowels, Retrum et al., 2011; Dougherty et al., 2007; Jurgens, 2006; Russell et al., 1998,
Thompson, 2006; Winters, 1999), the United Kingdom (Aldred et al., 2005), New
Zealand (Waterworth & Jorgensen, 2010) and Sweden (Brännström et al., 2006;
Brännström et al., 2007; Ekman et al., 2000; Falk et al., 2007; Nordgren et al., 2007).
Uncertainty was described in relation to symptoms (Aldred et al., 2005;
Bekelman, Nowels, Retrum et al., 2011; Brännström et al., 2006; Brännström et al., 2007;
Falk et al., 2007; Jurgens, 2006; Russell et al., 1998; Winters, 1999) and planning for the
future or anticipation of death (Aldred et al., 2005; Bekelman, Nowels, Retrum et al.,
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2011; Brännström et al., 2006; Brännström et al., 2007; Nordgren et al., 2007,
Waterworth & Jorgensen, 2010; Winters, 1999). Participants suggested that information,
supportive communication, trusting relationships, health care provider support, religion
or spirituality, and self-care behaviors helped them to deal with uncertainty (Brännström
et al., 2006; Brännström et al., 2007; Waterworth & Jorgensen, 2010; Winters, 1999).
Participants in a few studies expressed the ability to perceive positive outcomes from
their HF diagnosis, such as reframing their expectations, finding joy and meaning in their
lives, and focusing on new possibilities (Brännström et al., 2006, Nordgren et al., 2007,
Winters, 1999).
Quantitative assessments of uncertainty levels were obtained via the MUIS-C or a
Swedish-translated version of the CPS. For the most part, moderate levels of uncertainty
were reported (Ekman et al., 2000; Jurgens, 2006; Winters, 1999) Positive associations
were reported between uncertainty and spirituality (Thompson, 2006), HF-specific
somatic awareness (symptom severity; Jurgens, 2006), and tiredness and reduced
functional abilities (Falk et al., 2007). One nurse-directed education interventional, which
randomly assigned participants to groups, did not demonstrate significant differences in
uncertainty scores between the intervention and control groups (Ekman et al., 2000).
Growth Through Uncertainty
Results of both qualitative and quantitative studies indicate that uncertainty is
common in HF. As proposed within the RUIT, positive reappraisal of uncertainty may be
a stimulus for growth.
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Qualitative Studies
The Winters (1999) study reviewed above was the only investigation to provide
some qualitative support for the RUIT within an HF population. Winters suggested that
“In response to uncertainty, participants looked to the future, maintained a positive
outlook, and identified a positive outcome resulting from their illness” (p. 89). Mishel
and Murdaugh’s (1987) study of family adjustment to heart transplantation provided
preliminary qualitative support for how family members of patients with major cardiac
conditions process unpredictability and adopt a new life perspective in relation to three
phases of transplantation: (a) waiting for a heart, (b) hospitalization (transplant surgery
and the post-operative period), and (c) recovery and life after the transplant. Participants
were 20 family members (14 wives, 5 mothers, and 1 sister) of heart transplant recipients
or of individuals awaiting transplant who were willing to participate in support groups
focused broadly on their experiences. Support sessions were conducted over 12 weeks.
Data collection and analysis were concurrent using a grounded theory approach.
The major theme was redesigning the dream, which summarized the cognitive
and behavioral changes experienced by the family members through the phases of
waiting, hospitalization, and recovery. Those phases were characterized by the subthemes
of immersion, passage, and negotiation, respectively. Immersion and passage described
the cognitive and psychosocial changes experienced almost exclusively by the family
members, whereas the negotiation phase described how the family member and patient
integrated ongoing uncertainty into their future together. Throughout this process, the
family members restructured their views of reality to create a new normal. Mishel and
Murdaugh (1987) described how living with ongoing uncertainty resulted in a new view
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of reality in which family members redefined their expectations and integrated
uncertainty in their worldview. They did not, however, provide substantial support that
this process resulted in the positive appraisal of uncertainty or growth.
Fleury, Kimbrell, and Kruszewski (1995) explored the experiences of women
after an acute coronary event to better understand the psychosocial processes that support
their recovery. The sample consisted of 13 women in the United States: 4 had been
diagnosed with an acute MI, 5 had undergone CABG surgery, 2 had undergone PTCA,
and 2 had been diagnosed with myocardial ischemia. Data were collected from weekly
support group meetings over 9 months. Sessions were initiated with open-ended
questions about how participants were doing in general. Sessions were not recorded;
rather, the researchers took detailed notes after each session describing the content
discussed, observations, and group interactions.
The major theme that evolved from this study was healing, which was defined as
“an individual patterning that evolved over time and incorporated a struggle through the
uncertainty that surrounded the cardiac event to a way of creating a new and positive
health behavior change” (Fleury et al., 1995, p. 477). Fleury et al. (1995) characterized
this process as involving three nonsequential stages, surviving, originating, and
patterning balance. Surviving was characterized by instability that initiated changes in
personal worldviews. Originating involved developing new ways of living to reduce
cardiac risk in the face of uncertainties. Patterning balance was characterized by
reprioritizing life goals and values and redefining personal worldviews to effect positive
lifestyle changes. The authors argued that the process was congruent with the RUIT.
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Baier (1995) conducted a qualitative study exploring how individuals living with
schizophrenia and their family members experienced uncertainty to specifically assess the
applicability of Mishel’s (1990) RUIT to this population. She interviewed 6 individuals
with schizophrenia (4 females and 2 males) who were well controlled on antipsychotic
medications and 5 family members. Participants were recruited through a mental health
support group. Baier reported that all participants described uncertainty as part of their
illness experience and used probabilistic thinking defined as the ability to accept illness
uncertainty and perceive alternative ways of living to varying degrees. Uncertainty was
related to the effectiveness of drug therapy, symptom patterns, timing of relapses,
mortality, and managing family responsibilities. Some participants suggested that
uncertainty contributed to thoughts of fear, doubt, concerns, and obstacles, while one
participant and the four family members of the same relative were able to perceive hope
and optimism through their uncertainty.
Brashers et al. (1999) conducted a qualitative study exploring uncertainty in
people living with HIV who initially thought that they would die from their disease but,
due to successful treatment, were surviving. They recruited 33 individuals from an Adult
AIDS Clinical Trials Unit in the midwestern United States to participate in focus group
discussions. The interview guide focused on four main areas: (a) general experiences of
being HIV positive, (b) sources of uncertainty related to HIV status, (c) how uncertainty
impacted participants’ lives, and (d) strategies used to manage uncertainty. Latent content
analysis and constant comparative procedures guided data analysis. Participants described
uncertainty related to ambiguous symptoms, complicated treatment regimens, inadequate
education about diagnosis and prognosis, and the unpredictable disease trajectory. These
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findings were congruent with Mishel’s (1988) original UIT. Participants also discussed
the need to restructure certain facets of their lives (life priorities, financial support,
employment, interpersonal relationships, and long-term plans) to come to terms with a
new reality. The authors described this as a process of renegotiation that prompted new
uncertainties related to the future, social roles and identities, interpersonal relationships,
and quality of life. These accounts lent some support for growth as an outcome of
uncertainty as conceptualized within the RUIT.
Bailey, Wallace, and Mishel (2007) conducted a qualitative study with 10 men
diagnosed with localized prostate cancer within the previous year who had opted for a
watchful waiting approach. Time since diagnosis ranged from 4 months to 1 year.
Participants were interviewed once by the primary investigator, who asked broad
questions that addressed living with prostate cancer, treatment decision-making
processes, sources of uncertainty, and strategies to cope with uncertainties and other
illness challenges. Mishel’s (1990) RUIT served as the guiding theoretical framework for
this study and helped to organize findings into the following three categories: uncertainty,
appraisal of danger, and appraisal of opportunity. Uncertainty resulted from the limited
number of symptoms and ambiguous nature of symptoms, vague diagnostic and
prognostic indicators, and multiple treatment choices. Participants most commonly
appraised their illness and its uncertainty as danger as a result of unclear treatment
guidelines (need to obtain a second opinion, and watchful waiting vs. more aggressive
therapies), and treatment choices. Some participants did perceive their experience as
positive and viewed their future optimistically. Bailey et al. reported that several
participants “viewed their decision to watch and wait as an opportunity to successfully
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manage their uncertainty through work, self-care, keeping options open, and the use of
alternative medications and prayers” (p. 738).
Quantitative Studies
Mast (1998) examined correlates of illness uncertainty and emotional distress in
breast cancer survivors. The sample included 109 women, originally diagnosed with
nonmetastatic breast cancer (stage I-III), who were 1 to 6 years post-treatment. Length of
time since treatment ranged from 12 to 68 months, with a mean of 35 months. Mast
hypothesized that positive appraisal was associated with greater time since completion of
treatment and less emotional distress. They also hypothesized that time since treatment
completion was negatively correlated with emotional distress among those reporting
positive reappraisal. Positive reappraisal was measured using the GTUS. Emotional
distress was measured using the Profile of Mood States-Short Form (POMS-SF). Scores
on the GTUS (possible range, 39-234) ranged from 87 to 220 (mean 166; SD 28.1).
Women who reported higher unpredictability on the MUIS did reported less personal
growth. As hypothesized, GTUS scores were significantly and negatively correlated with
distress. Using hierarchical regression, GTUS scores made a significant independent
contribution to emotional distress controlling for coexisting illnesses, uncertainty, fear of
reoccurrence, and symptom distress; this model predicted 51% of the variance in
emotional distress. Mast (1998) did not find a significant association between length of
time since treatment and positive reappraisal or between length of time since treatment
and emotional distress. Furthermore, length of time since treatment did not predict higher
GTUS scores, contradicting a key premise of the RUIT, that perceiving uncertainty as
part of a new life view requires cognitive reframing over time.
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Mishel et al. (2005) and Gil et al. (2006) reported 10-month and 20-month
outcomes, respectively, from a randomized trial of a home-based uncertainty
management intervention for African-American (n = 149) and White (n = 360) breast
cancer survivors 5 to 9 years after treatment. Approximately 95% of the sample was
surveyed at the 20-month follow-up (Gil et al., 2006). The intervention materials
consisted of audiotapes of various cognitive strategies to promote emotion-focused
coping (relaxation, imagery, calming self-talk, and distraction) and a self-help manual
that reviewed information on symptoms and side effects of treatment, cancer resources,
and other content individualized to each participant’s needs. A trained nurse reinforced
this information and allowed the participants to practice one of the four cognitive
strategies during four weekly phone calls that lasted approximately 30 minutes. During
the phone call, the researcher also discussed managing uncertainty in general. The
women in the control group received usual care (Gil et al., 2006; Mishel et al., 2005).
At baseline, participants were initially blocked by race and then randomly
assigned to the experimental or control group. Data collected at baseline, 10 months, and
20 months included assessments of uncertainty, uncertainty management (cancer
knowledge, communication, social support, and cognitive reframing), coping, personal
growth, and negative mood state. Measures included a survivor version of the MUIS to
measure uncertainty, the Cancer Survivor Knowledge Scale to measure cancer
knowledge, the satisfaction subscale of the Social Support Questionnaire to measure
social support satisfaction, a patient–provider communication rating scale to measure
communication, the problem-solving and cognitive reframing subscale of the SelfControl Schedule to measure cognitive reframing, a modified version of the Coping
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Strategies Questionnaire to measure cognitive coping styles, a researcher-developed
questionnaire to measure adequacy and helpfulness of information as a facet of coping,
the POMS-SF to measure negative mood state, and the GTUS to measure personal
growth. A detailed overview of instrument selection that included a description of each
scale’s psychometric properties was provided (Gil et al., 2006; Mishel et al., 2005). A
research nurse not involved with baseline data collection or the intervention called each
participant monthly for 8 months to collect data on the uncertainty triggers and symptoms
that the women had experienced, the strategies used to deal with them, and the
effectiveness of each strategy (Mishel et al., 2005).
Descriptive statistics at 10 months indicated that the women used the audiotapes
to help manage their uncertainty between zero to nine times a month, with a mean of 2.24
(SD = 1.63); calming self-talk was used the most frequently (75%), followed by
distraction and relaxation (53%), and imagery was used the least (Mishel et al., 2005).
The women reported that all strategies except imagery were helpful. In addition, the
majority of women thought the manual was helpful in managing symptoms and referred
to it between zero and seven times a month, with a mean of 2.45 times per month (SD =
1.88; Mishel et al., 2005).
Results indicated that women in the treatment group reported significant
reductions in uncertainty, increased use of cognitive reframing, improved cancer
knowledge, greater use of distraction as a coping method, increased perceptions of the
amount and helpfulness of information, and consistent levels of personal growth at 20
months compared with baseline. In addition to significant improvements in total personal
growth scores, women in the treatment group also reported increases in the GTUS
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subscales, flexibility and a new view of life. In the control group, total personal growth
scores and flexibility and new view of life subscale scores decreased from baseline to 10
months and then decreased further from 10 months to 20 months. These findings were
more pronounced in African American women. Mishel et al. (2005) and Gil et al. (2006)
suggested that the results demonstrated preliminary evidence of effectiveness of a nursedirected cognitive behavioral intervention in reducing uncertainty and facilitating
personal growth through enhancing positive reappraisal skills in breast cancer survivors.
Porter et al. (2006) conducted a secondary analysis of the data from the
intervention trial (Gil et al., 2006; Mishel et al., 2005). The secondary sample included
524 long-term breast cancer survivors (all female; 369 Whites, 155 African Americans;
mean time since diagnosis = 81 [SD = 14] months; 85% stage I or II at diagnosis). The
purpose of this secondary analysis was to test a conceptual model (based in part on
concepts from the UIT and RUIT) of mood state and personal growth using structural
equation modeling. Predictors of mood state and growth included demographic variables
(age and education), disease factors (number of symptoms, symptom distress, and other
health problems), social factors (social support satisfaction and religious involvement),
negative cognitive factors (uncertainty, troublesome thoughts, and catastrophizing), and
cognitive reframing. The POMS-SF was used to measure negative mood state, and the
GTUS was used to measure personal growth.
Religious involvement and social support satisfaction directly strengthened
cognitive reframing in both White and African American participants. In both racial
groups, a greater number of symptoms, more religious participation, more education, and
younger age were directly correlated with greater personal growth. Although cognitive
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reframing was significant in predicting personal growth for both groups, there was a
larger effect in African American participants. Cognitive reframing also mediated the
influence of social support and partially mediated the influence of religious involvement
on growth. Negative cognitive state was directly correlated with less growth and
mediated the influence of symptom distress and social support satisfaction on growth in
both groups. In the final model for both ethnic groups, negative cognitive state explained
35% of the variance in negative mood state and 25% of the variance in growth, making
the largest contributions to the model. Cognitive reframing explained 21% of the variance
in growth for White women and 40% of the variance in growth for African American
women, providing support for the relationship between positive reappraisal and growth
proposed in the RUIT.
Bailey, Mishel, Belyea, Stewart, and Mohler (2004) tested the effectiveness of a
watchful waiting intervention for men with prostate cancer. The intervention incorporated
principles based on the RUIT, including cognitive reframing and positive reappraisal of
uncertainty. The sample consisted of 39 men diagnosed with prostate cancer (nearly all
Stage 1 or 2) who had opted for watchful waiting in place of more aggressive therapy.
The average duration of watchful waiting was 52 months. Participants were randomly
assigned to usual care or the intervention, which consisted of five weekly phone calls
from a study nurse that were focused generally on providing factual information while
encouraging probabilistic thinking to incorporate uncertainty into participants’
worldviews. In addition, the calls emphasized maintaining an optimistic outlook,
participation in activities, and ongoing awareness and monitoring of symptoms.
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Findings post-intervention did not demonstrate a statistically significant difference
between the intervention and control groups in total growth scores, although the increase
in GTUS scores for the intervention group (approximately 15 points) was substantially
greater than in the control group (approximately 5 points).
Santacroce and Lee (2006) examined relationships among post-traumatic stress
symptoms, uncertainty, and health promotion behaviors in young adult cancer survivors
(N = 45). They hypothesized that symptoms of post-traumatic stress mediated the
relationship between uncertainty and health promotion behaviors. As expected,
uncertainty was positively and significantly associated with post-traumatic stress
symptoms and inversely associated with health-promoting behaviors. Uncertainty and
post-traumatic stress had statistically significant negative bivariate correlations with
health-promoting behaviors. However, the hypothesized mediating role of post-traumatic
stress was not supported. When modeled together with uncertainty, the relationship
between post-traumatic stress and health-promoting behaviors was no longer statistically
significant, whereas the negative association between uncertainty and health-promoting
behaviors remained statistically significant and was similar in magnitude to the
relationship before the hypothesized mediator was added to the model. A respecified
model in which uncertainty mediated the relationship between post-traumatic stress and
health-promoting behaviors was better supported.
Y. L. Lee, Gau, Hsu, and Chang (2009) subsequently developed a conceptual
model of uncertainty, post-traumatic stress, and health behaviors in young adult and
adolescent survivors of childhood cancer based on an integrative, narrative literature
review. The model, based in part on the RUIT, proposed that reduced or time-limited
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uncertainty was conducive to developing a new view of life and health-promoting
behaviors (or decreases in risky health behaviors), whereas chronic, unresolved
uncertainty was a risk factor for post-traumatic stress disorder and risky health behaviors
(or decreases in health-promoting behaviors). However, the model posited post-traumatic
stress as a potential mediator between uncertainty and health-promoting behavior, which
was not supported in the earlier study by Santacroce and Lee (2006). The authors
acknowledged that the model was in need of empirical validation before it could be
claimed to support the RUIT.
Synthesis of Findings
In summary, a small number of qualitative and quantitative studies were either
informed by the RUIT or generated tentative support for uncertainty as a stimulus for
growth. These studies examined the illness experiences of people living with heart
disease (Fleury et al., 1995; Winters, 1999), schizophrenia (Baier, 1995), HIV (Brashers
et al., 1999), breast cancer (Gil et al., 2006; Mast 1998; Mishel et al. 2005; Porter et al.,
2006), prostate cancer (Bailey et al; 2004; Bailey et al., 2007), or childhood cancer
(Santacroce & Lee, 2006). In addition, one study examined experiences of family
members in the context of heart transplantation (Mishel & Murdaugh, 1987). Qualitative
sample sizes ranged from 10 (Bailey et al., 2007) to 33 (Brashers et al., 1999), whereas
quantitative sample sizes ranged from 39 (Bailey et al., 2004) to 524 (Porter et al., 2006).
The majority of studies were conducted in the United States, seven of which were
conducted by researchers affiliated with the University of North Carolina (Mishel’s
academic home). The majority of participants were female, with the exception of
participants in the HIV (Brashers et al., 1999) and prostate cancer (Bailey et al., 2004,
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2007) investigations. Most studies included a greater percentage of older participants,
with the exception of studies conducted by Baier (1995), Brashers et al. (1999),
Santacroce and Lee (2006), and Mishel and Murdaugh (1987). Although the majority of
participants were White, relevant ethnic differences between White and African
American breast cancer survivors were reported by Mishel et al. (2005) and Gil et al.
(2006).
Qualitative studies generated data related to growth through uncertainty by
broadly exploring general illness experiences (Fleury et al., 1995; Mishel & Murdaugh,
1987) or illness knowledge and future concerns (Baier, 1995). In addition to examining
the overall illness experience, two studies included an explicit focus on sources of
uncertainty and approaches to managing uncertainty (Bailey et al., 2007; Brashers et al.,
1999), providing data more congruent with appraisals of uncertainty. In particular, Bailey
et al. (2007) specifically used the RUIT to help organize findings during data analysis.
Data were collected in either group sessions (Brashers et al., 1999; Fleury et al.,
1995, Mishel & Murdaugh, 1987) or via one-time interviews (Baier, 1995; Bailey et al.,
2007). The use of group sessions and the lack of audiotaping in two studies (Baier, 1995;
Fleury et al., 1995) may have contributed to bias in study results. In two studies,
longitudinal data collection provided better insights related to how uncertainty is
processed over time (Fleury et al., 1995; Mishel & Murdaugh, 1987).
All of the qualitative studies concluded that some participants described the
ability to adopt a new life perspective through illness uncertainty via a process of
negotiation, redefining expectations, or restructuring ways of thinking or living. Themes
or findings characterizing this process included redesigning the dream (Mishel &
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Murdaugh, 1987), healing (Fleury et al., 1995), renegotiating the future (Brashers et al.,
1999), and danger and opportunity appraisals (Baier, 1995; Bailey et al., 2007). Although
a new view of reality was evident in all of these studies, this outcome was not
consistently characterized favorably by participants. For example, Baier (1995), Brashers
et al. (1999), and Mishel and Murdaugh (1987) reported, to a greater degree, new realities
largely formed by adverse thoughts and emotions. Reports of positive perceptions arising
from uncertainty in these studies were not as common, but when present, they described
hope or optimism for the future, personal or spiritual growth, or finding joy. In one study,
positive views reported by Baier (1995) were generated largely by members of the same
family, suggesting another potential bias. Although qualitative evidence to support
positive outcomes resulting from the appraisal of uncertainty is limited, this body of
literature did reveal participants’ abilities to reconstruct new realities that were
concurrently shaped by negative and positive perceptions.
Fleury et al.’s (1995) study provided qualitative support for integrating
uncertainty into positive cognitive changes, which is congruent with key propositions of
the RUIT, despite the study not being explicitly based on the RUIT. Fleury et al. (1995)
described this transition as an iterative process, which they characterized as being rooted
initially in chaos and instability that evolved over time to create favorable cognitive and
behavioral health changes. In conclusion, there is some qualitative, empirical support for
Mishel’s (1990) claim that individuals living with chronic illness can integrate
uncertainty into a new reality, but no conclusive evidence about whether that process
routinely results in the positive reappraisal of uncertainty, opportunity, or growth. Rather
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this qualitative synthesis suggests that some individuals are capable of perceiving
positive outcomes in the face of uncertainty.
In quantitative analyses, researchers discussed growth through uncertainty as a
process or an outcome and characterized it as positive reappraisal (Mast, 1998) or
personal growth (Bailey et al., 2004; Gil et al., 2006; Mishel et al., 2005; Porter et al.,
2006) and often referred to it interchangeably as a new view of life. Researchers either
examined relationships between this concept and other relevant variables (e.g.,
uncertainty, emotional distress, cognitive reframing, symptoms, comorbidities, social
support, religious participation, coping strategies, or time), or they examined differences
in these variables among groups. Quantitative investigations were conducted only with
cancer populations: one with prostate cancer patients (Bailey et al., 2004), one with
survivors of childhood cancers (Santacroce & Lee, 2006), and four with breast cancer
survivors (Gil et al., 2006; Mast, 1998; Mishel et al., 2005; Porter et al., 2006). Three of
these studies reported data from one larger program of research (Gil et al., 2006; Mishel
et al., 2005; Porter et al., 2006). The GTUS was used to measure positive reappraisal or
personal growth in all of these studies. All but one of the quantitative studies (Santacroce
& Lee) were conducted by investigators affiliated with the University of North Carolina.
Significant negative correlations were found in breast cancer survivors between
personal growth and unpredictability related to illness progression and prognosis (Mast,
1998) and emotional distress (Mast, 1998; Porter et al., 2006). Significant positive
correlations were found between personal growth and a greater number of symptoms,
more religious involvement, more education, and younger age (Porter et al., 2006).
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Studies that examined differences in personal growth were intervention studies
that evaluated the effects of interventions informed, to varying degrees, by the RUIT
(Bailey et al., 2004; Gil et al., 2006; Mishel et al., 2005). Whereas both interventions
addressed cognitive strategies to address uncertainty, the watchful waiting intervention
(Bailey et al., 2004) more fully incorporated key principles of the RUIT, such as
probabilistic thinking, integrating uncertainty into life, and positive reappraisal,
consistent with the study’s purpose, to help participants incorporate ongoing uncertainty
into a new worldview via cognitive reframing. The uncertainty management intervention
used in the other study, which aimed to help participants cope with uncertainty and
manage symptoms, was based on more traditional cognitive–behavioral strategies, such
as relaxation techniques and a more structured educational component. Significant
differences in reports of total personal growth at 10 months and 20 months in both
African American and White breast cancer survivors were found between the control and
intervention groups, but not in men living with prostate cancer at follow-up. Both studies
did report significant differences in the new view of life subscale of the GTUS at followup between the control and intervention groups.
Variations in findings most likely result from differences in population
characteristics and in the interventions. In particular, although Bailey et al. (2004)
provided a comprehensive description of key components of the watchful waiting
intervention, the intervention nurse individualized content based on the unique concerns
of each participant. It was not clear whether a structured template guided this intervention
and the extent to which various components of the intervention (probabilistic thinking,
incorporating uncertainty, optimism for the future, participation in activities, self-
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monitoring and vigilance) were emphasized. In contrast, the uncertainty management
intervention implemented with breast cancer survivors was based on specific topics and a
consistent and structured process, although some content could be tailored to individual
needs. Results from these two studies provide preliminary evidence that cognitive
strategies aimed to help process uncertainty can help facilitate aspects of personal growth
in cancer populations.
In addition to demonstrating whether uncertainty can serve as a stimulus for
growth, qualitative and quantitative studies provided data related to the influence of time
on the development of personal growth through uncertainty, a key premise within the
RUIT. Time was considered in terms of time since diagnosis or treatment or in the
context of phases of an illness (diagnosis, treatment, and recovery). Mishel and
Murdaugh (1987) collected data weekly over 12 weeks, and Fleury et al. (1995) collected
data weekly over 9 months, generating longitudinal qualitative insights that described
how coping with illness uncertainty evolved over time through specific phases and
resulted in a new reality in cardiac populations. Baier (1995) assessed the number of
years participants had been diagnosed with schizophrenia and considered time since
diagnosis in evaluating uncertainty as an opportunity; mixed responses limited the ability
to draw definitive conclusions from this study related to time and growth through
uncertainty.
Mast (1998) measured length of time since treatment and did not find a significant
correlation between time and positive reappraisal in breast cancer survivors. In contrast,
Mishel et al. (2005) and Gil et al. (2006) reported significant improvements in personal
growth over 10 months and 20 months, respectively, in an uncertainty management
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intervention group, and decreases in personal growth over this period in the control
group. Similarly, Bailey et al. (2004) reported significant improvements in the new view
of life subscale of the GTUS and, although not significant, trends toward total growth in
the intervention group at the 10-week follow-up. These findings suggest that time may
play a role in the appraisal of illness uncertainty, but there are not enough data to
conclude that time alone contributes to the positive appraisal of uncertainty as an
opportunity. Rather, interventions that promote cognitive restructuring of uncertainty, at
least in cancer populations, likely contribute to personal growth over time. The small
number of studies and variations in sample characteristics limit judgments about the
influence of time on growth through uncertainty.
Nature of Illness
The nature of an illness is conceptualized within the RUIT in terms of disease
pattern (acute vs. chronic vs. disease reoccurrence) and illness duration. As described in
Chapter 1, HF is a chronic disease resulting from structural and functional abnormalities
of the heart and is characterized by varying degrees of symptoms and activity limitations,
which can improve or worsen based on a variety of factors. The ACC/AHA guidelines
(Hunt et al., 2001) and NYHA classifications of HF, also described in Chapter 1, are used
to categorize HF’s disease stage and activity limitations. Disease patterns in HF can best
be understood in terms of disease stage (e.g., NYHA class), and changes in HF signs and
symptoms that lead to acute exacerbations of HF. Acute or progressive worsening of
chronic, stable HF results from increasing symptoms and/or deteriorating activity
tolerance when individuals (a) are nonadherent with diet or drug therapy, (b) affected by
a secondary physiological insult or concurrent illness, (c) experience adverse drug side
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effects or interaction, or (d) are no longer responsive to existing treatments (Jessup et al.,
2009). Clinical manifestations of acute exacerbations, such as respiratory distress, are
normally preceded by fluid overload, significant reductions in cardiac output, or a
combination of both (Jessup et al., 2009). Acute exacerbations (also referred to as acute
HF syndromes or acute decompensated HF) may be followed by extended periods of
stability (Hupcey et al., 2009; Jessup et al., 2009).
This unpredictable illness course complicates practitioners’ ability to determine
the number of years that someone can survive with HF (Hupcey et al., 2009; Jessup et al.,
2009). Duration of illness in HF is often considered in terms of prognosis. Although the
duration of time that an individual can live with HF has improved in recent years, the
most current evidence still indicates that 50% of individuals diagnosed with HF will die
within 5 years (Jessup et al., 2009; Levy et al., 2006). Sudden cardiac death from
ventricular arrhythmias also contributes to mortality in HF. Although sudden cardiac
death is more common in end-stage HF (stage D), individuals in less advanced stages can
still succumb to sudden death (Jessup et al., 2009). In summary, although guidelines exist
to categorize patterns in HF and guide prognosis, in general, the overall nature of HF
remains unpredictable.
Symptom Status
Over the last several decades, researchers have conceptualized symptoms in a
variety of ways. Leventhal and Johnson (1983) defined symptoms within their theory of
self-regulation as the actual representations of illness experienced by an individual via
cognitive processing, characterizing the symptom as an objective occurrence distinct
from an individual’s emotional response to it. Rhodes and Watson (1987) emphasized the
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subjective nature of symptoms, characterizing symptoms as a change perceived by an
individual that is reflective of abnormalities in functioning, sensation, or appearance.
Similarly, Lenz, Pugh, Milligan, Gift, & Suppe (1997) defined symptoms, within their
middle-range theory of unpleasant symptoms, as perceived markers of alterations in
normal functioning experienced by an individual. They also suggested that symptoms are
multidimensional, they can be experienced individually or in combination, and symptom
assessment should not only address the presence or absence of a symptom, but should
also consider the frequency, severity, and distress associated with the symptom. Dodd et
al. (2001) defined symptoms as subjective experiences that represent alterations in
normal biopsychosocial abilities, cognition, or sensations; they are typically distressful
and indicators of deteriorating health.
Understanding how an individual interprets a symptom (the meaning a person
attributes to a symptom) is another important facet of more recent conceptualizations of
the symptom experience (Armstrong, 2003). Symptom experience has been characterized
as “the perception of the frequency, intensity, distress, and meaning occurring as
symptoms are produced and expressed,” in which the situational and existential meaning
of symptoms and the collective influence of multiple symptoms are considered
(Armstrong, 2003).
Within the RUIT, symptoms are conceptualized in terms of pattern, that is, “the
degree to which symptoms are present with sufficient consistency to be perceived as
having a pattern or configuration,” and in terms of event congruence, that is, “the
consistency between the expected and the experienced illness-related events,” in this
case, symptoms (Mishel, 1990, p. 59). In the literature, researchers using this framework
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have evaluated symptom pattern in terms of symptom ambiguity (inability to recognize a
symptom as related to a particular illness) and severity of symptoms. The event
congruence of symptoms has been evaluated via the predictability of the symptom
(ability to predict the frequency, onset, duration, intensity, location, and meaning of a
symptom) (Mishel & Clayton, 2008). For the purposes of this study, symptom status was
conceptualized as an individual’s ability to perceive symptoms and components of a
symptom pattern to include occurrence, frequency, severity, distress and overall burden.
In HF, inadequate cardiac output and insufficient venous return contribute to the presence
of symptoms, such as dyspnea or abdominal fullness (Kemp & Conte, 2012). As
described in Chapter 1, select symptoms during activity (notably fatigue, dyspnea,
palpitations, and angina) contribute to the NYHA classification system, which is used to
stage HF and as an approximate indication of prognosis. Therefore, although symptoms
are a key component of disease severity, they do not on their own capture the full scope
of disease severity. By the same token, estimates of disease stage do not entirely account
for symptom severity. Consequently, disease severity in this study will be operationally
defined as NYHA stage, whereas symptom status cannot be equated to disease stage.
Symptom Patterns in HF
There is a large body of literature exploring symptoms in HF. Researchers have
generated knowledge related to symptom status in HF through studies that explore the
experience of HF broadly (Bekelman, Nowels, Retrum et al. 2011; Hopp et al., 2010; Yu
et al., 2007); focus on specific symptoms, such as fatigue or dyspnea (Austin, Williams,
& Hutchison, 2012; Falk et al., 2007; Jones, McDermott, Nowels, Matlock, & Bekelman,
2012; Parshall et al., 2001); assess HF symptoms in general (Janssen, Spruit, Uszko-
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Lencer, Schols, & Wouters, 2011; Janssen et al., 2008; Walke et al., 2007); or evaluate
symptom clusters (Jurgens, Moser et al., 2009; C. S. Lee et al., 2014; K. S. Lee et al.,
2010; Song, Moser, Rayens, & Lennie, 2010). Research questions include how HF
symptoms are related to comorbidities (Austin et al., 2012; Janssen et al., 2011; Jurgens,
Hoke, Byrnes, & Riegel, 2009; Jurgens, Moser et al., 2009; Walke et al., 2007), age
(Janssen et al., 2011; Jurgens, Hoke et al., 2009; Jurgens, Moser et al., 2009; Riegel et al.,
2010; Zambroski, et al., 2005), gender (Austin et al., 2012; Jurgens, Hoke et al., 2009; K.
S. Lee et al., 2010; Zambroski et al., 2005), HRQOL (Bekelman et al., 2007; Opasich et
al., 2008; Zambroski et al., 2005), and overall morbidity or mortality (Ekman et al., 2005;
Gallagher et al., 2012; C. S. Lee et al., 2014; Moser et al., 2011).
Researchers have used terms such as detect, recognize, identify, appraise, and
experience somewhat interchangeably to characterize cognitive processes whereby
individuals perceive symptoms. Symptom perception is assessed primarily via patient
self-reports (spontaneous or in response to questionnaires or clinical interview). Selfreports may be real-time or retrospective based on patient recall, interviews, or medical
record review (Lam & Smeltzer, 2012). Recall may involve questions about the usual
pattern of the symptoms experienced over some recent time interval (e.g., past week or 2
weeks), or a specific episode (Parshall et al., 2012). Symptom perception is often
discussed in terms of symptom severity, but terms that are used to convey symptom
severity in the HF literature (e.g., burden, distress) are often used imprecisely and
inappropriately, as though they were synonymous, even when they refer to different
constructs (Landrum, 2009). The use of multiple descriptors, diverse instruments, and
variations in aims of existing studies make it difficult to compare studies or draw
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definitive conclusions from findings related to symptom perception, intensity, and
predictability in HF (Landrum, 2009). For that reason, studies of symptoms in HF need to
be examined closely to determine what was measured, as well as how and when it was
measured. In this chapter, the focus is on studies that address symptom perception or
reporting in HF in terms of patterns of occurrence, severity, or distress as relevant to
evaluating HF or patient decisions to seek care.
Comorbidities
Comorbidities are common in individuals living with HF (Janssen et al. 2011). In
a large cross-sectional study drawn from a random sample of all Medicare recipients in
the United States (N = 122,630; aged 65 years or older), Braunstein et al. (2003) reported
that more than 40% of participants had five or more comorbid conditions, of which the
most common were HTN (55%), diabetes mellitus (31%), COPD (26%), eye conditions
(24%), and high cholesterol levels (21%).
Walke et al. (2007) conducted an observational cohort study that examined the
impact of comorbidities on the range and severity of symptoms reported by individuals
living with either COPD (n = 74) or HF (n = 59; NYHA class III or IV). Participants
were interviewed every 4 months for up to 24 months; 93 participants completed all
phases of follow-up. Symptoms evaluated during data analysis included physical
discomfort, pain, fatigue, lack of appetite, depression, anxiety, and shortness of breath.
Symptom burden, which characterized a total symptom severity score, was calculated by
totaling the individual symptom scores. Symptoms reported by the HF cohort in order of
frequency included physical discomfort, fatigue, lack of appetite, shortness of breath,
pain, depression, and anxiety. Symptoms present at baseline were not associated with
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survival. The frequency of reports of shortness of breath, fatigue, pain, and depression
increased significantly over time. The number of participants assessing symptoms as
moderate to severe increased from baseline to follow-up for all symptoms. Using linear
mixed-effects models, Walke et al. (2007) explored the relationships among symptom
burden, length of time in the study, number of comorbidities, and survival. Symptom
burden increased over time and in relation to an increased number of comorbidities, but
not to a statistically significant degree.
Age, Gender, and Quality of Life
In some HF studies, age and gender have been explored in relation to symptom
perception and quality of life. In a sample of 77 men and women, aged 65 years and
older, Jurgens, Hoke et al. (2009) explored factors associated with symptom recognition
and response in an elderly cohort receiving care for worsening HF in the emergency
center or in an inpatient unit of a tertiary care facility in the northeastern United States.
The sample consisted of 40 men and 37 women; 66% were White, 48% were married,
and the majority had at least a high school education. Approximately 80% of the
participants met criteria for functional performance consistent with NYHA class III or
IV.
Perception of symptom distress was measured using a researcher-modified
version of The Heart Failure Somatic Perception Scale (HFSPS). The Response to
Symptoms Questionnaire was used to measure cognitive, emotional, and social factors
impacting symptom response. Researchers also collected data on HF history, symptom
duration, onset, and care-seeking decisions. In addition, they conducted interviews with
participants to better understand contextual factors that influenced decision-making and
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care-seeking. Jurgens, Hoke et al. (2009) found that 56% of their participants were unable
to identify HF symptoms or recognize their significance. Age, comorbidities, and gender
did not contribute to significant differences in symptom distress scores. Almost half of
the sample reported experiencing shortness of breath for more than 3 days prior to
seeking medical care, but a majority of participants did not know that their symptoms
were related to their HF diagnosis. Among participants who had been hospitalized for HF
previously (n = 53), approximately 20% did not know the etiology of their symptoms and
were inclined to attribute HF symptoms to other causes, such as colds or strenuous
activity.
Riegel et al. (2010) examined differences in symptom identification and
interpretation between two age groups of individuals with NYHA class II-III: younger
than 73 years of age (n = 13) and 73 years of age or older (n = 16). Most participants
were male, were married, were born in Australia, had a high school education, and met
criteria for NYHA class II. The only significant difference between age groups was a
higher percentage of retired individuals in the older group. To assess symptom detection,
the participants and a researcher rated shortness of breath and perceived exertion before,
immediately after, and 5 minutes after a 6-minute walk test (6MWT) using a visual
analog scale and the Borg scale of perceived exertion. Ratings between the participants
and the researcher were compared for differences in scores (the ability to detect
symptoms) and then compared by age groups. Inter-rater reliability was established
between two researchers employing the 6MWT on patients not enrolled in this study.
Inter-rater reliability was highest for the Borg scale (0.91). Results showed that, at each
time point, there were greater discrepancies between the older participants’ ratings of
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their shortness of breath and the researcher’s assessments, compared with the younger
participants’ and researcher’s ratings. Significant differences between age groups in
symptom detection were only found in ratings collected immediately after the 6MWT.
In addition, qualitative semistructured interviews were conducted to better
understand the participants’ ability to detect and interpret their symptoms. Riegel et al.
(2010) found that older individuals with HF had greater difficulty in identifying and
interpreting shortness of breath and fatigue as relevant to their HF management compared
with younger persons; older participants attributed shortness of breath to being out of
shape, fatigue to poor sleep or excessive daytime activity, and ankle edema to arthritis.
Younger participants reported the ability to independently recognize symptoms earlier
and therefore act on them. Younger participants also perceived symptoms as having an
adverse impact on their daily lives, which increased their self-monitoring, whereas older
participants perceived their health more favorably and, as a result, were less attentive to
the effects of their HF. Consistent with Winters’ (1999) study, Riegel et al. (2010) found
that older participants experienced greater uncertainty related to symptom identification.
Zambroski et al. (2005) evaluated the impact of age and gender on symptom
prevalence, severity, distress, and burden, and the influence of these factors on HRQOL
in a sample consisting of 53 participants recruited from an outpatient HF clinic in the
midwestern United States. Participants were predominantly male (66%), with a mean age
of 55 years (SD = 9.6), 89% were non-Hispanic White, 64% were married, and the
majority met criteria for NYHA class III (57%). Participants completed a symptom
assessment using the Memorial Symptom Assessment Scale–Heart Failure (MSAS-HF),
a 32-item scale that asks the participants to rate the frequency, severity, and distress of
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physical, psychological and HF-specific symptoms experienced during the last week,
using a Likert scale. Symptom burden scores were the mean of the frequency, severity,
and distress scores for each symptom. Results related to symptom prevalence, severity,
distress, and burden, and relationships with age and gender were reviewed.
More than 60% of the sample reported the following symptoms in order of
decreasing prevalence: shortness of breath (85.2%), lack of energy (84.9%), dry mouth
(74.1%), feeling drowsy (67.9%), difficulty sleeping (64.2%), and worrying (61.5%).
Symptoms reported as having the greatest frequency (at least occasionally or more
frequently as reported by > 85% of participants), in ascending order, included feeling
bloated, worrying, shortness of breath, diarrhea, numbness/tingling in hands and feet,
difficulty concentrating, other (non-chest) pain, lack of energy, poor appetite, and
difficulty sleeping. The most severe symptoms (at least moderately severe) reported by
this sample included change in the way food tastes (100%), difficulty sleeping (96.8%),
other pain (90%), lack of energy (88.6%), shortness of breath (88.6%), numbness and
tingling in the hands and feet (87%), and feeling drowsy (87%). Participants reported that
lack of energy (63.6%), difficulty sleeping (60.6%) and shortness of breath (60.5%) were
the most distressful and that shortness of breath, other pain, feeling bloated, poor
appetite, change in the way food tastes, numbness/tingling in hands and feet, problems
with sexual interest/activity, and lack of energy were the most burdensome (Zambroski et
al., 2005).
Significant differences by gender in baseline characteristics included that men
were more likely to be married and have a high school education compared with women.
Significant gender differences related to prevalence, severity, distress, and burden
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included the following: significantly more women than men reported feeling nervous and
sweating, and men reported a significantly higher frequency of sexual problems that were
significantly more distressing and burdensome (after controlling for marital status),
compared with reports by women (Zambroski et al., 2005).
Significant differences related to age included the following: nausea was
significantly more prevalent in older participants (patients 55 years and older) compared
with younger participants (54 years or younger), and shortness of breath and waking up
breathless at night were significantly more distressing and burdensome in younger
participants. The only significant difference in baseline characteristics between the older
and younger groups was that older participants were more likely to be taking
antiarrhythmic medications. Using hierarchical stepwise regression, the authors found
that after controlling for age and NYHA class, symptom prevalence and symptom burden
made independent contributions to explained variance in HRQOL. Younger age, worse
functional status, and greater symptom prevalence and burden predicted decreased
HRQOL in this sample.
Opasich et al. (2008) assessed symptom severity in a study designed to test the
appropriateness of the Edmonton Symptom Assessment Scale (ESAS) in a cardiac
population and to assess the relationship between symptoms and global health status or
quality of life. The sample consisted of 46 inpatients admitted to an Italian medical
facility with late-stage HF (NYHA class III or IV). The sample was mostly male (57%),
with a mean age of 71 years (SD = 11) living with HF for a mean duration of 42 months
(SD = 36). Symptom intensity was measured using the original 10-point ESAS. The
ESAS was administered two times a day (morning and afternoon) for 5 days. A total
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daily score for each symptom was calculated by adding the morning and afternoon scores
and generating a mean score. An overall symptom distress score was calculated by
adding mean scores of the total daily symptom scores from the 5 days. Global health
status was measured using the Kansas City Cardiomyopathy Questionnaire (KCCQ)
summary score.
Although shortness of breath was reported as the most frequent symptom (100%),
generalized discomfort, tiredness, and anorexia were found to be more distressing than
shortness of breath. The authors suggested that participants may have become
accustomed to ongoing shortness of breath and therefore did not rate it as distressing. In
addition, total symptom distress scores were correlated with the KCCQ summary score
(r = –0.78; p = .0001), but none of the individual symptoms independently predicted
quality of life.
Symptom Variability and Clinical Outcomes
Other researchers have also focused explicitly on the variability of symptom
occurrence and severity. Webel, Frazier, Moser, and Lennie (2007) evaluated daily
changes in patients’ reports of dyspnea, edema, and weight gain for 1 month. A
secondary aim of this study was to explore the relationships among dyspnea, edema, and
body weight. Forty-eight individuals diagnosed with HF participated in this study. The
mean age was 48 years (SD = 15), 55% were male, 54% were married, and the majority
met criteria for NYHA class III (54%). Each day for 30 days, participants rated their
shortness of breath and edema on a 0-to-10 scale, with 0 indicating the absence of the
symptom and 10 indicating maximal symptom severity. To measure body weight,
participants weighed themselves on the same scale, at the same time, each day. The
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sample, as a whole, reported consistent and moderate levels of daily dyspnea, but
individual participants differed in the variability of symptom intensity from day to day.
The sample was divided into a stable group (n = 26; 62%) and an unstable group (n = 16;
38%), based on conventional criteria for clinical stability/instability. The unstable group
demonstrated greater variability in symptom intensity over the 30-day period compared
with the stable group. Moderate changes in edema were also reported for the group as
whole, with minor to moderate fluctuations over time. A subset of participants, who
typically reported consistent levels of edema for extended periods, at certain time points,
reported drastic increases in the extent of their edema. Webel et al. suggested that sudden
changes in HF stability (exacerbations) or the inability of participants to accurately assess
more subtle alterations in edema could account for this finding. A positive and a
significant association was present between dyspnea and edema daily reports every day
for 30 days, whereas dyspnea and edema were not significantly correlated with body
weight for the majority of study days. The authors recognized that individual assessments
of symptom severity may not be interpreted consistently among participants, making it
difficult to objectively compare reports, and that the addition of a functional assessment
would most likely improve the ability to detect symptom variability.
Moser et al. (2011) examined symptom variability as a predictor of event-free
survival in 71 individuals living with HF (NYHA class I/II 45%; class III/IV 49%; not
documented 6%). Participants had a mean age of 62 years (SD = 14), 59% were male,
87% were White, and 63% were married or lived with a significant other. Comorbidities
were reported as follows: HTN (63%), previous MI, CABG or coronary intervention
(58%), diabetes (37%), reduced kidney function (20%), stroke (13%), and peripheral
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vascular disease (PVD; 14%). Participants rated shortness of breath, swelling, fatigue,
and difficulty sleeping every day for 30 days using the Daily Symptom Scale. This
instrument assesses symptom severity on a 0-to-10 scale, with 0 indicating the absence of
the symptom and 10 indicating the highest symptom severity. The researchers conducted
monthly phone follow-ups to assess outcomes of event-free survival, specifically
hospitalizations and/or death, and then verified verbal reports with hospital records.
Ten nurses with HF expertise used consensus procedures to organize symptom
patterns using graphic representations of daily reports into the following categories: mild,
moderate, or severe symptoms and high or low symptom variability. In addition, for each
participant, 30-day symptom scores were totaled to derive a mean symptom score as a
measure of symptom severity. Symptom variability for each participant was determined
using standard deviations of the symptom scores over the 30-day period. The median of
the standard deviations was used to categorize scores into a high variability and a low
variability group. More than 95% of the participants reported experiencing each of the
four symptoms during the 30 days. Approximately 94% of participants reported shortness
of breath, 90% reported difficulty sleeping, 89 % reported fatigue, and 82% reported
edema, to varying degrees, every day. On the whole, symptom ratings were low to
moderate in severity.
Associations between symptom severity scores were assessed for each
combination of symptoms and found to be both positive and significant, indicating that as
the severity of one symptom increased, so did the severity of the others. Correlations
between symptom variability scores were positive and significant for all symptom
combinations, with the exception of fatigue and edema. Furthermore, an inverse
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relationship was found between severity of shortness of breath and variability of
shortness of breath, indicating that as variability increased, severity decreased.
Participants who reported more variability in their shortness of breath and/or
edema were more likely to be hospitalized compared with those who reported less
symptom variability. Using Cox proportional hazards models, the authors found that
symptom variability related to shortness of breath and edema predicted event-free
survival independent of age, gender, symptom severity, ejection fraction, and
comorbidities. Symptom severity did not predict event-free survival.
Ekman et al. (2005) examined the predictive ability of self-reported severity of
symptoms (breathlessness, fatigue, angina, orthopnea, and edema) on worsening HF,
hospitalization, and mortality in a sample of 3,029 individuals. This study was a
secondary analysis of a large, multicenter, randomized controlled trial which was
conducted in 15 European countries to evaluate the effectiveness of beta-blocker therapy
on HF outcomes. Participants were mostly men (79%), with a mean age of 62 years and
designated as NYHA class II (48%), NYHA class III (48%), or NYHA class IV (4%).
Breathlessness, fatigue, and angina were evaluated using a 5-point scale that assessed the
presence of symptoms with different degrees of activity; orthopnea was measured as
present or absent, and edema was measured as present or absent and by location. Data
were collected at baseline and every 4 months for a mean of 58 months.
Univariate analysis revealed that breathlessness, orthopnea, and fatigue were
significantly associated with mortality and deteriorating HF and that angina was
significantly associated with mortality and all-cause hospitalization. The influence of
symptom severity on selected outcomes was assessed using Cox proportional hazards
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models controlling for multiple baseline characteristics (age, gender, NYHA
classification, duration of illness, cause of HF, comorbidities, and drug therapy).
Breathlessness significantly predicted increased mortality and all-cause hospitalization,
and fatigue significantly predicted worsening HF, after controlling for baseline
characteristics.
Gallagher et al. (2012) examined patterns and duration of symptoms prior to a
first-time hospitalization for HF. Participants were recruited from an Australian HF
registry (N = 242, 54% male; mean age = 79 years). A majority of participants met
criteria for NYHA class II (38%) or III (24%). Participants were asked about the
occurrence and duration of 10 HF-specific symptoms prior to their admission. The
researchers used this information to construct two variables: duration of acute symptom
onset and symptom pattern (gradual onset vs. multiple symptoms occurring
simultaneously and more rapidly).
Participants reported having experienced up to seven symptoms (mean = 2.7) for
a median of 4.5 (range, 1-7) days prior to hospitalization. The most frequently reported
symptoms were worsening dyspnea on exertion (88%), swelling (49%), and cough
(27%). Approximately one third of participants reported multiple simultaneous symptoms
rather than a gradual onset of symptoms. Participants sought hospitalization more quickly
for chest pain, worsening dyspnea with exertion, and nocturnal dyspnea, indicating that
these symptoms were perceived as more intense or concerning. Symptom duration prior
to hospitalization increased if symptoms occurred during the hours of 8:30 am to
midnight versus in the middle of the night and if symptoms changed. Symptom duration
decreased prior to hospitalization if participants experienced chest pain or were older.
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Parshall et al. (2001) examined the impact of dyspnea duration, distress, and
intensity on individuals’ decisions to go to the emergency department (ED) and on
admission status. The sample consisted of patients with an established diagnosis of HF (N
= 57, 54% female) treated in a university hospital ED. The researchers collected data
retrospectively via phone, in-person interviews, and/or medical record review. Prior to
asking questions specifically about dyspnea, the researchers asked broad questions about
the general nature of the symptoms that prompted the participant to seek emergency care.
Data were also collected on demographic and clinical factors, daily activities, quality of
life, and the participants’ comprehension of and compliance with HF management. The
Specific Activity Scale (Goldman et al., as cited in Parshall et al., 2001) was used to
measure functional status. To measure dyspnea distress, participants were asked to rate
how much their breathing bothered them using a 5 point scale, with responses ranging
from 0 (not at all) to 4 (very much), at two recalled time points: the time that they
decided to go to the ED (Decision) and 1 week prior to this decision (Week Before).
Duration was the number of days that the participants experienced dyspnea at the severity
level reported at Decision. Participants were also asked what terms they would use to
describe the breathing distress they experienced at the time they decided to go to the ED.
Dyspnea intensity was measured using two versions of a researcher-developed dyspnea
descriptor checklist (Elliot et al., 1991, and Simon et al., 1990, as cited in Parshall et al.,
2001), which asked participants to select the descriptors that best characterized how their
breathing felt prior to seeking emergency care and then to rate their intensity on a 0-to-10
scale, with 10 indicating the highest severity. Eleven items from this checklist were used
to evaluate dyspnea intensity.
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The majority of participants indicated that their HF symptoms routinely limited
their ability to perform meaningful activities. Twenty three percent indicated that a
primary concern at the time that they decided to go to the ED was related to functional
limitations, with most (~70%) reporting an increase in dyspnea severity at this time,
followed by reports of chest pain (~30%, cf. Gallagher et al., 2012; Parshall, 1999). At
the Week Before time point, dyspnea distress was categorized by 39% as minimal or
absent, by 15% as somewhat distressful, and by 46% as very distressful. At the Decision
point, 12% reported dyspnea distress as minimal or absent, 8% reported it as somewhat
distressful, and 80% reported it as very distressful, indicating an overall increase in
distress over the week preceding the visit. Nearly half of the participants used distressladen words, such as couldn’t breathe, couldn’t get air, smothering, or choking in
response to open-ended questioning. More than one third added emotional descriptors,
such as awful or terrible, to further emphasize their distress.
Approximately two thirds of participants recalled 3 days or less of dyspnea,
whereas one third reported a duration of 6 days or more. Distress reports were not
significantly different at the Decision point for participants reporting different durations
of dyspnea (3 days or less vs. 6 days or more), and dyspnea duration prior to the ED visit
was not associated with admission to the hospital. For the sample as a whole, the mean
intensity rating was 6.7 (SD = 2.7) points at Decision and 4.4 (SD = 3.3) points 1 week
prior. Those who experienced dyspnea for 6 or more days reported high levels of distress
and intensity at both Week Before and Decision time points, whereas the participants
experiencing dyspnea for 3 days or less had lower reports of distress and intensity 1 week
before the visit that increased substantially over a few days prior to the visit.
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Symptom Clusters and Clinical Outcomes
Researchers have also studied the combined occurrence of multiple symptoms in
HF populations to identify symptom clusters that may help individuals living with HF
perceive their symptoms earlier and identify symptoms that are significant to their HF
management. In a secondary analysis, Jurgens, Moser et al. (2009) retrieved data from
the Heart Failure Quality of Life Trialist Collaborators registry to identify symptom
clusters in hospitalized HF patients. The secondary sample consisted of 687 participants
with a mean age of 71 years; 51% were female, 61% were White, and most participants
were classified as either NYHA class III (45%) or class IV (38%). Participants assessed
symptoms using nine items from the Minnesota Living with Heart Failure Questionnaire
(MLHFQ): six physical symptoms and three emotional symptoms. The researchers used
principal components analysis with oblique rotation to determine the following symptom
clusters: (a) acute volume overload (shortness of breath, fatigue, and sleeping problems),
(b) chronic volume overload (swelling, increased need to rest, and dyspnea on exertion),
and (c) emotional (depression, memory problems, and worry). The authors found that, in
general, older participants more frequently reported symptom clusters, but participants 75
years and older reported less overall symptom impact. Diabetes was the only comorbidity
that was a significant independent predictor of a symptom cluster (emotional).
Using an agglomerative hierarchical clustering method, Song et al. (2010)
identified a dyspnea cluster (shortness of breath, orthopnea, and awakening breathless
from sleep) and a weary cluster (lack of energy and appetite, and problems sleeping) in a
sample of 421 patients hospitalized with HF in Korea. In this study, the mean age was 62
years; 40% were female, and most were classified as either NYHA class II (38.2%) or
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class III (34.2%). Participants reported symptom occurrence and severity over the
previous 2 weeks using a modified version of the MSAS-HF, which addressed the
following symptoms: shortness of breath, lack of energy, difficulty sleeping, orthopnea,
waking up breathless at night, lower extremity or ankle edema, dizziness, chest pain,
palpitations, and poor appetite. Using hierarchal Cox proportional hazards regression
analysis, Song et al. (2010) found that increased severity related to the weary cluster
independently predicted hospital readmission for a cardiac-related problem and that
increased severity associated with the dyspnea cluster independently predicted cardiac
death.
Finally, K. S. Lee et al. (2010) used data from 3 prospective longitudinal studies
that included HF participants recruited from three outpatient settings in different states to
better understand the influence of individual characteristics on symptom clusters and the
effect of symptom clusters on morbidity and mortality. Sample characteristics included a
mean age of 61 years; 65% were male, 81% were White, and 44% were classified as
NYHA class III. Symptoms were assessed using eight items from the MLHFQ (edema,
dyspnea, fatigue/increased need to rest, fatigue/low energy, sleep problems, worrying,
feeling depressed, and cognitive problems). Using cluster analysis, the authors identified
the following symptom clusters for both men and women: the physical cluster (dyspnea,
fatigue/increased need to rest, fatigue/low energy, sleeping problems) and the
emotional/cognitive cluster (worrying, depression, and cognitive disturbances). Edema
constituted a third, single-symptom cluster. Total symptom distress scores from the
physical and emotional/cognitive clusters were correlated (r = .64, p < .01). The
emotional/cognitive distress cluster was associated with younger age, and women were
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significantly more likely than men to report greater physical distress. After controlling for
age, gender, comorbidities, body mass index, NYHA class, and interaction between
emotional/cognitive and physical clusters, total distress from the emotional/cognitive
cluster was a significant independent predictor of cardiac events (a composite of death,
hospitalization, or HF-related ED visit). Compared with participants categorized as low
distress on both the physical and emotional/cognitive clusters, participants categorized as
high distress on both clusters or on just the emotional/cognitive cluster were more than
twice as likely to experience a cardiac event. The likelihood of a cardiac event was not
increased among participants categorized as high physical distress only compared with
those categorized as low distress on both the physical and emotional/cognitive clusters.
C. S. Lee et al. (2014) recently examined physical and psychological HF
symptom profiles in relation to 1-year event-free survival (a composite of all-cause
mortality, cardiac-related ED visit or hospitalization, cardiac transplant or ventricular
assist device implantation). This prospective cohort study included 202 individuals
recruited from an outpatient HF setting in the Pacific northwest. The mean age was 56.9
years, 50% of participants were male, 85.6% were White, and most met criteria for
NYHA class III (55.9%) or class II (40.1%). To evaluate physical symptoms, participants
completed the HFSPS, an 18-item scale that asks participants to rate how much they have
been bothered by HF-specific physical symptoms on a 6-point scale (0 = did not have
symptom; 5 = extremely bothersome). Researchers also collected data on daytime
sleepiness using the Epworth Sleepiness Scale (ESS), depression using the 9-item Patient
Health Questionnaire (PHQ9), anxiety and hostility using the Brief Symptom Inventory
(BSI), and clinical event outcomes via electronic medical record review or patient report.
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The researchers used latent class mixture modeling to distinguish symptom profiles using
continuous HFSPS, ESS, and BSI anxiety and hostility scores and a binary PHQ9 score
cut point (depressed, not depressed). Significant positive linear associations (range, .27.66) existed among the four symptom measures. The researchers used symptom severity
categories to create three distinct profiles of increasing symptom burden/severity: mild
(41.7% of sample), moderate (30.2% of sample), and severe (28.1% of sample). None of
the individual symptom measures independently predicted 1-year event-free survival, but
the severity profiles did. After controlling for the Seattle Heart Failure Score (a proxy for
disease severity), compared with the mild symptom profile (reference category),
participants in the moderate (hazard ratio [HR] = 1.8, 95% CI: 1.1-3.1) and severe (HR =
2.1, 95% CI: 1.2-3.5) symptom classes were significantly more likely to experience at
least one of the composite endpoint events within 1 year.
Synthesis of Findings
In summary, researchers have examined symptoms in relation to occurrence,
severity, and variability. They have also explored the influence of comorbidities, age, and
gender on symptom patterns and the influence of symptom patterns on clinically
important outcomes. Findings suggest that individuals living with HF experience a
multitude of symptoms, of which shortness of breath and fatigue are the most frequent
and distressing (Janssen, et al., 2011; Janssen et al., 2008; Jurgens, Hoke, et al., 2009;
Parshall et al., 2001; Song et al., 2010). Other common HF symptoms include insomnia,
pain, generalized discomfort, muscle weakness, edema, depression, anxiety, cough,
anorexia, dry mouth, nausea, palpitations, dizziness, and difficulty concentrating and

74
urinating (Gallagher et al., 2012; Janssen et al., 2011; Janssen et al., 2008; Jurgens, 2006;
Opasich et al., 2008; Walke et al., 2007; Zambroski et al., 2005).
Studies of symptom clusters are limited and somewhat idiosyncratic (i.e.,
primarily descriptive of specific samples with little agreement across studies). Symptom
clusters have been characterized as pertaining to acute versus chronic volume overload
and emotional symptoms (Jurgens, Moser et al., 2009); physical versus
emotional/cognitive symptoms (K. S. Lee et al., 2010); and dyspnea versus weary
clusters (Song et al., 2010). An alternate approach, creating composite severity classes
based on multiple symptom indices (C. S. Lee et al., 2014), has also been used.
Although these studies indicate that individuals living with HF report a wide array
of symptoms, variations in sample characteristics and design contribute to differences
related to symptom perception, severity, and predictability. Mixed results related to
symptom perception, severity, and predictability and the influence of comorbidities, age,
and gender on these characteristics need to be considered in relation to variations in
sample sizes and geographical regions. Primary studies in this review used sample sizes
ranging from 29 (Riegel et al., 2010) to 421 (Song et al. 2010), whereas secondary
analyses were conducted with data obtained from sample sizes ranging from 26 (Jones et
al., 2012) to 3,029 (Ekman et al., 2005). Researchers recruited participants from diverse
locations, including the Netherlands (Janssen et al., 2011), the United States (Jones et al.,
2012; Jurgens, Hoke et al., 2009; Jurgens, Moser et al., 2009; C. S. Lee et al., 2014; K. S.
Lee et al., 2010; Moser et al., 2011; Parshall et al., 2001; Walke et al., 2007; Webel et al.,
2007; Zambroski et al., 2005), Korea (Song et al., 2010), Italy (Opasich et al., 2008), the
United Kingdom (Austin et al., 2012), and throughout Europe (Ekman, et al. 2005).
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Researchers assessed symptom patterns using the MLHFQ (or a subset of items)
(Austin et al., 2012; Jurgens, Moser et al., 2009; K. S. Lee et al., 2010), the ESAS
(Opasich et al., 2008; Walke et al., 2007), the MSAS-HF (Song et al., 2010; Zambroski et
al., 2005), the HFSPS (Jurgens, Hoke et al., 2009; C. S. Lee et al., 2014), the Borg scale
of perceived exertion (Riegel et al., 2010), the Daily Symptom Scale (Moser et al., 2011),
and visual analog or numeric rating scales for various symptoms (Janssen et al., 2011;
Parshall et al., 2001; Riegel et al., 2010; Webel et al., 2007), or researcher-developed
rating scales (Ekman et al., 2005; Gallagher et al., 2012; Parshall et al., 2001). The
variety of instruments and approaches to measuring symptom severity or distress
complicates comparisons across studies.
Even when the same instrument was used, researchers varied time frames. For
example, Zambroski et al. (2005) and Song et al. (2010) both used the MSAS-HF, but
Song et al. (2010) used a modified version and asked participants to evaluate their
symptoms over the last 2 weeks, whereas Zambroski et al. (2005) used the original
version and asked participants to assess their symptoms over the last week.
The ability to assess variations in symptom perceptions or severity over time was
limited by the use of cross-sectional study designs (Gallagher et al., 2012; Janssen et al.,
2011; Jurgens, Hoke et al., 2009; C. S. Lee et al., 2014; Opasich et al., 2008; Parshall et
al., 2001; Riegel et al., 2010; Song et al., 2010; Zambroski et al., 2005). Longitudinal
data provided greater insights related to symptom variability over time. For example,
Walke et al. (2007) demonstrated increases over 2 years in reports of and severity of HFspecific symptoms, such as shortness of breath and fatigue, as well as in symptoms that
are less specific for HF, such as pain and depression.
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Although comorbidities are important in clinical management, their relevance to
severity, frequency, or patterns of HF symptoms is less clear. In examining contributions
of comorbidities (lung disease, diabetes, renal disease, and PVD) to symptom clusters,
Jurgens, Moser et al. (2009) found that diabetes mellitus was the only comorbidity to
predict a symptom cluster (the emotional cluster) in patients with HF. Participants
reporting high physical and emotional/cognitive distress in K. S. Lee et al.’s (2010) study
had more comorbidities. Finally, Walke et al. (2007) found that symptom burden
increased over time in relation to a higher number of coexisting illnesses, but this
relationship was not statistically significant.
Findings that described the relationship between age and symptom pattern
characteristics in HF also varied, in part because of widely variable criteria for age group
comparisons across studies. Janssen et al. (2011) did not find a significant relationship
between the number of symptoms and age in an HF group with a mean age 76.2 years.
Alternatively, Jurgens, Moser et al. (2009) found that older age (75 years or older) made
significant contributions to three symptom clusters. Also within this study, although older
participants reported more symptoms, the impact of symptoms on their lives was less
distressful compared with the younger group. This finding is consistent with findings of
K. S. Lee et al. (2010) that participants who reported less emotional/cognitive distress
were older. Jurgens, Hoke et al. (2009) found that age did not make significant
contributions to differences in symptom distress scores, but that the majority of
participants in this elderly cohort (65 years and older) were unable to identify HF
symptoms or recognize their significance.
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In Riegel et al.’s (2010) study, significant differences in symptom identification
between the younger group (younger than 73 years) and the older group (age 73 years or
older) were only found immediately after a 6MWT, not before or 5 minutes after the
6MWT. Similar to findings from Jurgens, Hoke et al.’s (2009) study, qualitative data also
indicated that the older group had more difficulty in identifying and interpreting shortness
of breath and fatigue as relevant to their HF management compared with the younger
group. Older participants attributed shortness of breath to being out of shape, fatigue to
poor sleep or excessive daytime activity, and ankle edema to arthritis (Riegel et al.,
2010). Zambroski et al. (2005) found that nausea was significantly more common in
older participants (patients 55 years and older) compared with younger participants (54
years or younger), and shortness of breath and waking up breathless at night were
significantly more distressing and burdensome in younger participants.
Only a few studies found significant differences in symptom patterns by gender.
Zambroski et al. (2005) found that a greater number of women reported feeling nervous
and sweating compared with men. Men reported significantly greater reoccurrence of
sexual problems and significantly more distress associated with sexual problems.
Although K. S. Lee et al. (2010) found that women reported significantly greater distress
from select symptoms (fatigue/increased need to rest, sleep problems, and depression)
compared with men, the authors did not detect significant differences by gender in
symptom clusters. In addition, Jurgens, Hoke et al. (2009) did not find significant
differences in symptom distress scores by gender.
In conclusion, HF is characterized by a wide array of symptoms that may occur in
isolation or together with varying degrees of frequency, severity, and patterns of onset or
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relief. Some individuals living with HF may not recognize that certain symptoms are
likely due to their HF. Ambiguity in symptom patterns and the unpredictability of these
patterns contribute to uncertainty in HF and create challenges for individuals living with
HF over time. Researchers’ ongoing attention to a better understanding of symptom
patterns and how these patterns can impact clinically important outcomes and patientcentered care highlights the significance of symptom management as a key component of
improving the experience of living with HF.
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CHAPTER 3
METHODS

This chapter addresses: (1) study design; (2) specific aims and research questions;
(3) site and setting; (4) sample; (5) study procedures, including recruitment, enrollment,
consent, data collection, and handling; (6) variables and measurements; (7) data analysis;
and (8) human protection issues.
Study Design
A descriptive, exploratory design with cross-sectional data collection was used to
examine reports of personal growth and to explore potential relationships between
personal growth and relevant demographic, clinical, and cognitive factors in communityresiding adults living with class II-IV HF. This research was guided by Tedeschi and
Calhoun’s (2004) work on PTG and Mishel’s (1990) RUIT. A convenience sample of
participants meeting study criteria was recruited from an outpatient cardiology clinic.
Once informed consent was obtained, participants were asked to complete questionnaires
assessing personal growth, uncertainty, and symptoms. In addition, demographic and
clinical data were collected either via participant self-report, provider report, or through a
medical record review.
Specific Aims and Research Questions
The specific aims of this exploratory study were to: (1) describe levels of personal
growth in adults living with NYHA class II-IV HF; (2) explore the relationship of
personal growth with age, sex, ethnicity, disease severity, time since diagnosis, symptom
status, and uncertainty levels; and (3) determine the extent to which variance in personal
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growth in individuals living with NYHA class II-IV was accounted for by age, sex,
ethnicity, disease severity, time since diagnosis, symptom status, and uncertainty. The
following research questions addressed these specific aims:
1. Do adults living with NYHA class II-IV HF report personal growth following
their diagnosis of HF?
2. To what extent are age, sex, ethnicity, disease severity, time since diagnosis,
symptom status, and uncertainty levels associated with personal growth in
individuals with HF?
3. Which variables (age, sex, ethnicity, disease severity, time since diagnosis,
symptom status, or uncertainty levels) make independent contributions to personal
growth in individuals living with NYHA class II-IV HF?
Site and Setting
This study was conducted at an outpatient cardiology clinic located in San
Antonio, Texas. San Antonio is the seventh largest city in the United States and the
second largest city in the state of Texas (City of San Antonio, 2012). Approximately,
1,785,704 individuals live in San Antonio and the surrounding area of Bexar County,
which spans approximately 1,240 square miles (U.S. Department of Commerce, 2012). In
Bexar County, more than 60% of the population is 18 years and older, with 10.4% of the
population estimated to be 65 years and older. Approximately 50.9% of this population is
female. People of Hispanic or Latin origins make up the majority (58.9%), whereas
White persons of non-Hispanic origin make up 30.2% of the population (U.S.
Department of Commerce, 2012).
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The cardiology clinic serves a large local and referral HF population. The practice
was established in 1975 and currently employs three physician providers and two
advanced practice nurses (APNs). HF patients are primarily managed by one physician
and one APN. Patients classified as NYHA class II are seen at least annually and NYHA
class III-IV patients are seen weekly to monthly, based on their level of stability. The
goal of the HF clinic is to optimize outpatient treatment to prevent hospital admissions
(V. Paparelli, personal communication, September 13, 2014).
Sample
A convenience sample was recruited from this outpatient cardiology clinic.
Inclusion criteria for the participants were (1) adults (≥ 18 years of age) with NYHA
class II-IV HF, (2) community-residing, (3) able to speak and understand English, and (4)
capable of providing informed consent. Exclusion criteria were (1) pregnant women, (2)
children (< 18 years of age), and (3) prisoners.
Sample size was estimated using G*Power (version 3.17; Heinrich Heine
Universität Düsseldorf, 2013). The target sample established for this study was 120 to
achieve 80% power to detect a medium standardized effect size (f2 = .15, equivalent to a
model R2 = .13 against a null hypothesis that R2 = 0) at an alpha error level of .05 for a
regression model with up to seven predictors, while allowing for up to 15% incomplete or
nonreturned surveys.
Recruitment, Enrollment, and Consent
Prior to submitting the protocol to the Human Research Review Committee
(HRRC) at the University of New Mexico (UNM) Health Sciences Center, I made initial
contact with an APN, who had been working in a local cardiology clinic for several
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years, helping to manage the clinic’s HF population. Over the next 3 months, the two of
us communicated on a regular basis to assess the feasibility of conducting my study at
this clinic. Subsequently, the clinic provided a letter of support to the HRRC, indicating
that they were willing and eager to serve as the primary research site for the study, that
the target sample size was realistic and achievable based on their current population, and
that they were prepared to help ensure that study procedures met the requirements of the
HRRC.
After obtaining approval from the HRRC at UNM, recruitment commenced.
Participants were recruited primarily through recruitment flyers (Appendix C), which
were available in the office and given to HF patients by providers during scheduled
appointments. The role of the clinical staff was limited to providing the flyer, verifying
patients’ interest in learning more about the study, and referring potentially interested
patients to me. If potentially eligible participants verbalized interest in the study and I
was present in the clinic, I met with them in person before or after scheduled
appointments. If I was not available in the clinic, initial contact occurred over the phone,
at the request of the patient, and a time was scheduled to meet in person at the clinic. At
this time, I provided interested participants with a verbal and written description of the
study and screened them for eligibility.
In addition to the use of flyers as a recruitment strategy, I also sent recruitment
letters to potentially eligible patients (Appendix D), which indicated that the study was
ongoing and had the endorsement of the clinic. A Health Insurance Portability and
Accountability Act (HIPAA) Waiver of Authorization for recruitment only, obtained
from the HRRC, permitted review of medical records using HF diagnostic criteria to
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identify potentially eligible participants who may not have had scheduled appointments
during the recruitment phase. A total of 180 recruitment letters were mailed. I received 16
calls from individuals who had received letters. Three of these individuals chose not to
participate, expressing concerns related to distance, a recent change in cardiology
providers, and, in one case, a limited ability to understand English. Thirteen of the callers
were interested in participating and most set up appointments to meet with me at the
clinic during a scheduled appointment or at a time that was mutually convenient and were
subsequently enrolled in the study. In a few cases, individuals were unable to meet me in
person, so a modification request was obtained from HRRC to allow me to screen
participants over the phone and obtain signed consent and HIPAA authorization through
the mail.
In all cases, after screening potential participants for eligibility, a signed informed
consent and HIPAA Authorization for Use and Disclosure of Protected Health
Information (Appendix E) was obtained from all who agreed to participate. Participants
were given a copy of the combined informed consent/HIPAA document after a copy was
scanned into their medical record.
A total of 107 individuals were enrolled in the study. Two participants withdrew:
1 female participant, who had a phone interview scheduled, called to indicate that she
was too busy to participate, and 1 male participant called after completing the survey data
to indicate that he no longer felt comfortable participating in the study. In addition, 2
participants did not return the survey data, resulting in a final sample of 103, which was
adequate to achieve 80% power based on the power analysis.
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Data Collection and Handling
Once informed consent and HIPAA authorization were obtained, each participant
was assigned a unique study identification (ID) number. Participants were asked to
complete the following questionnaires: (a) a demographic and clinical questionnaire, (b)
the PTGI (Appendix F), (c), the MUIS-C (Appendix G), and (d) MSAS-HF (Appendix
H). These questionnaires were combined into one survey that did not include any
protected health information (Appendix I). Supplementary clinical data were obtained
from the medical record or via provider report and stored in a separate data file that could
be linked to the survey data by study ID number (Appendix J). Both the survey data file
and the clinical data file were stored in REDCapTM (Research Electronic Data Capture),
an encrypted, web-based data collection system developed specifically to ensure
confidentiality of study records. REDCapTM is made available to UNM Health Sciences
Center faculty by the UNM Clinical and Translational Science (CTSC).
Participants were given the option of completing the survey electronically or on
paper. Electronic access was via a secure web portal to REDCapTM from the electronic
device of the participant’s choice. Participants who did not feel comfortable completing
the surveys electronically or did not have Internet access completed paper copies of the
survey either in person or via the mail. Participants were also given the option to
complete the survey via a phone or in-person interview conducted by the researcher. All
data that were documented on paper by either the participant or the researcher were
entered into REDCapTM by the researcher as soon as possible. Original copies of surveys
were kept in a locked file cabinet, separate from any files that included identifiable
information and were only accessible to the primary researcher.
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Variables and Measures
Variables examined in this study included personal growth (the dependent
variable included in the regression analysis) and the following independent or predictor
variables: age, sex, ethnicity, disease severity, time since diagnosis, symptom status, and
uncertainty.
Demographic and Clinical Data
Demographic and clinical data that were collected and examined as predictor
variables in this investigation included age; sex; ethnicity; NYHA class, as a measure of
disease severity; and time since diagnosis in years. In addition, to better assess significant
differences in population characteristics and to support possible additional exploratory
analyses, the following data were also collected: race, years of education, highest
educational degree, marital/partner status, etiology of HF, number of hospitalizations
within the last year for HF, ejection fraction (if documented within the last year) and how
ejection fraction was established, comorbidities, and current cardiac medications.
Demographic data were collected as part of the combined questionnaire (Appendix I).
Clinical data were predominantly collected by the researcher through a medical record
review or, in a few cases in which clinical data were not available in the medical record,
via provider report (Appendix J).
Growth
Personal growth was measured using total growth scores from the PTGI
(Tedeschi & Calhoun, 1996). The PTGI is a 21-item instrument that measures an
individual’s perceptions of favorable changes that occur as a result of dealing with a
traumatic life event (see Appendix F). It consists of the following five domains: (a) new
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possibilities (5 items); (b) relating to others (7 items); (c) personal strength (4 items); (d)
appreciation of life (3 items); and (e) spiritual change (2 items). For items within each
domain, participants are asked to rate the degree of change that occurred as a result of
their adverse life event on a 6-point Likert scale, with zero indicating no change and five
indicating the greatest degree of positive change. A total growth score is calculated by
adding the individual items scores. The maximum total growth score that can be obtained
is 105.
Although the PTGI was originally developed and tested in a sample of healthy
college students, it has been widely used in older individuals with medical illnesses,
including populations with cancer, heart disease, HIV, and neurological, orthopedic, or
burn injuries (Barskova & Oesterreich, 2009). Initial construct validity was established
by comparing total PTG scores from a group of individuals who reported experiencing a
major trauma in the last year with scores from a group of individuals who denied
experiencing a major trauma in the last year. Participants who reported a major trauma
reported greater growth and results were significant (Tedeschi & Calhoun, 1996).
Concurrent validity was established by demonstrating significant, positive
correlations between total PTG scores and scores of optimism, extraversion, openness to
experience, agreeableness, conscientiousness, and religious involvement, personality
factors and variables theoretically thought to be related to growth. Correlations between
total PTG scores and scores of neuroticism were not associated, supporting discriminant
validity (Tedeschi & Calhoun, 1996). In addition, to ensure that PTG scores did not
simply reflect social desirability, correlations between PTG scores and scores from the
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Marlowe-Crowne Social Desirability Scale were analyzed and found to be unrelated
(Tedeschi & Calhoun, 1996).
In a review of growth measurement scales, Park and Lechner (2006) reported
scale intercorrelations ranging from r = 0.62 to r = 0.83, Cronbach’s alpha values ranging
from 0.67 (appreciation of life subscale) to 0.90 (total growth score), and adequate test–
retest reliability values over 2 months for the total growth score (r = 0.71), but weaker
test–retest reliability values for select subscales, such as the personal strength scale (r =
0.37). Test–retest reliability assessments may not be the most appropriate measure of
reliability because personal growth may not reflect a stable construct. Studies that used an
English version of the PTGI in populations with heart disease demonstrated Cronbach’s
alpha values for total growth scores of 0.96 (Leung et al., 2010; Sheikh, 2004). Leung et
al. (2010) also reported Cronbach’s alpha values for the individual subscales as follows:
new possibilities, 0.87; relating to others, 0.92; personal strength, 0.85; appreciation of
life, 0.74; and spiritual change, 0.87.
Symptom Status
Symptom status was measured using the MSAS-HF, which is a 32 item
instrument that assesses the presence, frequency, severity, and distress of symptoms
experienced in HF (Zambroski et al., 2004; Appendix H). The MSAS-HF is a modified
version of the original Memorial Symptom Assessment Scale (MSAS) which was
designed for use in cancer populations (Portenoy et al., 1994). The MSAS-HF includes
five additional HF-specific symptoms (chest pain, palpitations, waking up breathless at
night, difficulty breathing while lying flat, and weight gain) and excludes five of the
original cancer-related symptoms (don’t look like myself, mouth sores, hair loss,
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difficulty swallowing, and changes in skin). The MSAS-HF consists of the following
three subscales, physical symptoms, psychological symptoms, and HF-specific
symptoms.
Participants initially indicate the presence or absence of a variety of symptoms
over the previous week. If a symptom is present, the participant is then asked to assess its
frequency on a 1- to 4-point scale, with 1 indicating rarely and 4 indicating almost
always, and to report both its severity on a 1- to 4-point scale, with 1 indicating mild
severity and 4 indicating very severe, and its distress on a 0- to 4-point scale, with lower
scores indicating no distress and 4 indicating very much distress. Higher scores indicate
greater symptom frequency, severity, and distress. Consistent with guidelines established
by Portenoy (1994) for the original MSAS and adopted by Zambroski et al., (2004),
distress scores are calculated using the following scale: 0.8 for not at all, 1.6 for a little
bit, 2.4 for somewhat, 3.2 for quite a bit, and 4 for very much. A total symptom
prevalence score is calculated by adding the number of symptoms present. A symptom
burden score is calculated by adding the symptom frequency, severity, and distress scores
of individual symptoms, as applicable, and determining the mean. A total symptom
burden score is determined by summing the symptom burden scores for each symptom
and then determining the overall mean of all reported symptoms. In this study, the total
symptom burden score was used to measure symptom status.
Construct validity of the MSAS-HF was established by demonstrating greater
symptom prevalence in an HF population compared with healthy adults not diagnosed
with HF (Zambroski et al., 2004) and supported by findings that demonstrated significant
associations between symptom presence and burden scores and HF HRQOL (Bekelman
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et al. 2007; Zambroski et al., 2005) Preliminary reliability of the MSAS-HF has been
established (Zambroski et al., 2004). Zambroski et al. (2005) reported Cronbach’s alpha
coefficients of 0.92 for the total symptom score, 0.83 for the psychological subscale, 0.87
for the physical subscale, and 0.73 for the HF-specific subscale. Song et al. (2010) used a
modified version of the MSAS-HF to measure prevalence and distress of select physical
symptoms and reported a Cronbach’s alpha coefficient of 0.81.
Uncertainty
Uncertainty was measured using the MUIS-C. The MUIS-C is a 23-item, onefactor scale that was developed from the original MUIS-A (Mishel, 1981) to measure
perceived uncertainty in illness in individuals not acutely ill or hospitalized (Mishel,
1997). The MUIS-C contains the same items as the MUIS-A, with the exception of items
related to treatment and communication in a hospital setting (Appendix G). Participants
respond to questions using a 5-point Likert scale, with 1 indicating strongly disagree and
5 indicating strongly agree. After reverse scoring select items according to established
instructions, items are summed to provide a total uncertainty score. Composite
uncertainty scores range from 23, reflective of low levels of uncertainty, to 115,
indicative of very high levels of uncertainty.
Construct validity and sensitivity have been established in studies primarily using
the original MUIS-A (Mishel, 1997). Cronbach’s alpha values for the MUIS-C have been
reported to be between 0.53 and 0.92, with the majority in the moderate-to-high range
(Mishel, 1997). In an HF population, Jurgens (2006) reported a Cronbach’s alpha of 0.78.
In other cardiac populations, a Cronbach’s alpha of 0.87 has been reported (Carroll,
Hamilton, & McGovern, 1999).
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Normative data synthesized from 20 studies using the MUIS-C in a variety of
illness populations indicated no differences in mean uncertainty scores related to sex or
age, but demonstrated a differences in mean uncertainty scores related to education, with
mean uncertainty scores decreasing with greater education (Mishel, 1997).
Data Analysis
Statistical analysis was performed using IBM® SPSS® Statistics (version 22).
Preliminary analyses using descriptive statistics and graphical displays were conducted to
check for missing data or out-of-range values and to describe the sample. For
demographic and clinical data and questionnaire scores, descriptive statistics included
frequencies and percentages, means and standard deviations, or medians and percentages,
as appropriate, based on measurement level and distributional characteristics. In addition,
preliminary analyses were used to help assess assumptions for planned statistical
procedures.
Internal consistency of the measures of growth, uncertainty, and burden scores for
each symptom were assessed using Cronbach’s alpha coefficients. Inter-item correlations,
Cronbach’s alpha if the item was deleted, and corrected item total correlations were also
reviewed. (Cronbach’s alpha cannot be estimated for the total burden score because
individuals differ in the symptoms they report.)
Bivariate correlations between continuous variables (age, time since diagnosis,
total growth scores, total symptom burden scores, and total uncertainty scores) were
analyzed using Pearson product-moment correlation coefficients. Hierarchical multiple
regression with variables entered in three successive blocks was conducted to determine
whether PTGI scores were predicted by a model consisting of the following independent
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variables: age, sex, ethnicity, disease severity, time since diagnosis, symptom burden
scores, and uncertainty scores. Demographic variables (age, sex, and ethnicity) were
entered first, followed by clinical variables (disease severity and time since diagnosis)
and then total symptom burden and uncertainty scores.
Analysis to determine which predictors made significant independent
contributions to the model, while controlling for the other predictors in the model, was
planned. Supplemental analyses assessed whether assumptions of normality, linearity,
homoscedasticity, multivariate outliers, and independence of residuals were satisfied and
whether multicollinearity was problematic.
Two-sample t tests were conducted to determine whether personal growth scores
differed by sex, ethnicity, and disease severity. For any significant differences, pointbiserial correlations were used as an effect size estimate. Additional exploratory analyses
were performed to generate a better depiction of symptom prevalence and burden and
reports of uncertainty in this sample.
Human Protection
This study was approved by the HRRC at UNM. The study did not include any
vulnerable populations. Each phase of the study, from recruitment to completion, was
clearly outlined in the HRRC-approved protocol to ensure adherence to principles of
responsible conduct of research with human subjects. Participants who were eligible and
agreed to participate signed a combined informed consent and HIPAA Authorization for
Use and Disclosure of Protected Health Information (Appendix E). The HIPAA
authorization allowed the researcher to access the participants' medical record for clinical
information relevant to the study; these data were clearly described within the informed
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consent. The informed consent provided a detailed description of the study so that the
participants had all the information they needed to make an informed choice about
whether to participate given the study’s risks and benefits. Participants were reassured
that their involvement was voluntary and that declining to participate would not impact
their usual medical care. Participants were notified that they could withdraw from the
study at any time without any adverse ramifications.
Because the study primarily involved questionnaire measures and did not involve
sampling of blood or tissues, risks of participation were mainly fatigue or distress from
answering several questionnaires. The questionnaires themselves did not involve
questions about highly sensitive matters, but did focus on significant life events in
relation to a diagnosis of HF. Participants were informed that they could skip any
questions that made them uncomfortable, stop answering questions at any time, or
withdraw if they preferred. Participants were also given the choice of how they preferred
to complete the survey (on paper, electronically, or via a researcher-conducted interview)
to minimize fatigue, distress, or any perceived inconvenience from completing multiple
questionnaires. There were no direct benefits to participation, but participants were
informed that the results of the study were expected to enhance understanding of
psychosocial aspects of HF and could contribute to future improvements in care that may
benefit others with the condition. Once the survey was completed and returned,
participants were given a $20.00 gift card as a token of appreciation for their time and
effort.
As with all research, there was a risk of loss of confidentiality and/or privacy. A
HIPAA Waiver of Authorization for recruitment only was approved by the HRRC to
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facilitate recruitment of potentially eligible participants not seen in the clinic during the
recruitment phase. In addition, the primary researcher signed a Medical Record Access
Agreement, Confidentiality and Non-Disclosure Agreement, and HIPAA Confidentiality
Agreement with the cardiology clinic. Names and addresses of potentially eligible
participants were documented on a recruitment tracking form that was kept in a locked
file cabinet in a secure office space, only accessible to the primary researcher.
Recruitment letters were addressed by hand by the primary researcher while in the clinic
and mailed as soon as possible, at which time, the recruitment tracking form was
destroyed.
Participants who agreed to take part in the study signed an informed consent and
HIPAA authorization form that clearly outlined potential risks. Participants were also
provided a copy of this document for their records. To minimize the risk of loss of
confidentiality, participants’ names and other identifying information was maintained in a
locked file cabinet, separate from the survey data, in a secure office space, only
accessible to the primary researcher. At the completion of the study, any personal
identifying information and any record linking that information to the study identification
numbers were shredded and destroyed. For any survey data entered into REDCapTM and
subsequently exported to SPSS, the only identifiers were unique study identification
numbers, which were assigned to each participant. Only members of the research team
had access to these data. These data were stored and accessible to the research team for a
period consistent with the policies and procedures of the UNM CTSC and HRRC.
To protect participants’ privacy, participants were only approached if they
verbalized interest in learning more about the study after receiving a recruitment letter or
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a flyer. Recruitment materials clearly indicated that participation was voluntary and
outlined how to contact the researcher if an individual was interested. Private space in the
clinic was provided to the primary researcher to meet with interested patients to discuss
the study, obtain informed consent, and complete the survey if participants chose to do so
while in the clinic.
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CHAPTER 4
RESULTS

A sample of 103 participants completed the surveys. The majority (58%)
completed the surveys via an in-person interview with the researcher, 40% completed the
surveys on paper, and 2% completed the surveys electronically. Survey responses entered
into REDCapTM and exported to SPSS were reviewed for missing data. Participants
responded to all clinical and demographic questions, with the exception of 3 participants
who did not answer the question regarding the number of years of education; however,
those individuals did respond to the item addressing highest educational (degree) level.
Survey questionnaires had a minimal amount of missing data. Participants had been
informed that they could skip questions that made them uncomfortable or that they
preferred not to answer. Eight cases included missing data for only one or two items on
the combined questionnaires. In one case, a participant did not respond to six items on the
MUIS-C and one symptom on the MSAS-HF. This individual wrote “No answer fit” next
to items that were skipped on the MUIS-C. The highest percentage (4%) of missing data
on any one item addressed problems with sexual interest/activity on the MSAS-HF. Of
the cases with missing data, six were completed on paper, two via in-person interview,
and one electronically.
Sample Description
Sample demographic and clinical characteristics are shown in Tables 1 and 2. The
sample was predominantly White, male, married or living with a partner, and educated at
or above the high-school level, with ages ranging from 27 to more than 90 years.
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Table 1
Demographic Characteristics (N = 103, except as noted)
Characteristic
N (%)
Mean (SD)
Age, years
73.71 (12.58)
Sex
Male
78 (75.7)
Female
25 (24.3)
Married or living with a partner
Yes
72 (69.9)
No
31 (30.1)
Race
Asian
1 (1.0)
African American
2 (1.9)
White
96 (93.2)
Other
2 (1.9)
Prefer not to answer
2 (1.9)
Ethnicity
Hispanic
19 (18.4)
Not Hispanic
83 (80.6)
Prefer not to answer
1 (1.0)
Highest number of years
14.82 (3.51)
a
of education
Highest educational level
< 12 years
5 (4.9)
High school graduate/GED
44 (42.7)
Associate’s degree
6 (5.8)
Bachelor’s degree
26 (25.2)
Graduate degree
22 (21.4)
__________________________________________________________________
a

N = 100.

In most cases, ischemic heart disease was documented as the cause of HF. The
majority of participants met criteria for NYHA functional class II or III. Diabetes and
pulmonary disease were the two most common noncardiac comorbidities, followed by
peptic ulcer disease, cancer, chronic kidney disease, and peripheral vascular disease.
More than half of the sample had lived with a diagnosis of HF for more than 10 years
(range 1 to 30 years).
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Table 2
Clinical Characteristics (N = 103 except as noted)
Characteristic
Ejection fraction documented within last yeara
≤ 40%
> 40%
Etiology of heart failureb
Ischemic heart disease
Hypertension
Cardiomyopathy
Other
NYHA functional class
II
III
IV
Hospitalized within last year for heart failure
Significant medical history
Peripheral vascular disease
Stroke
Diabetes
Chronic pulmonary disease
Connective tissue disorder
Cancer
Peptic ulcer disease
Chronic kidney disease
Depression
Anxiety/mood disorder
Medications
ACE inhibitor
Angiotensin receptor blocker
Beta blocker
Diuretic
Digoxin
Vasodilator
Milrinone
Years since diagnosis
0-1 year
2-3 years
4-5 years
6-9 years
10-19 years
20-29 years
≥ 30 years

n (%)
45 (49.5)
46 (50.5)
67 (65.0)
19 (18.4)
38 (36.9)
7 (6.8)
53 (51.5)
46 (44.7)
4 (3.9)
40 (38.8)
18 (17.5)
9 (8.7)
35 (34.0)
34 (33.0)
4 (3.9)
28 (27.2)
29 (28.2)
26 (25.2)
17 (16.5)
11 (10.7)
53 (51.5)
26 (25.2)
92 (89.3)
82 (79.6)
28 (27.2)
30 (29.1)
13 (12.6)
6 (5.8)
8 (7.8)
13 (12.6)
18 (17.5)
24 (23.3)
17 (16.5)
17 (16.5)

Note. NYHA = New York Heart Association; ACE = angiotensin converting enzyme.
a
N = 91; 12 participants did not have an ejection fraction documented within the last year. bSome
participants had multiple etiologies documented.
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Personal Growth in HF
Total growth scores from the PTGI were examined to answer the first research
question, “Do adults living with NYHA class II-IV HF report personal growth following
their diagnosis of HF?” Only one case had missing data for a single item that addressed
improvements in religion. The PTGI total growth score demonstrated very good internal
consistency (Cronbach’s α = .96); the deletion of any single item on the PTGI did not
improve reliability. Inter-item correlations ranged from .23 to .75, with a mean of .52.
The weakest correlation (r = .229) was between the items I discovered that I am stronger
than I thought I was and I changed my priorities about what is important in life. The
corrected item total correlations ranged from .59 to .78.
The mean for the total growth score was 48.6 (SD = 28.6), with a range of
possible scores of 0 to 105, indicating that this sample reported experiencing a moderate
degree of personal growth as a result of their HF diagnosis. Responses to individual items
ranged from 0, if the participant did not experience any degree of change, to 5, indicating
that the participant experienced a change to a very great degree as a result of his or her
HF diagnosis. As shown in Figure 1, four items had modal categories greater than or
equal to 4, indicating that participants experienced change in these areas either to a great
or very great degree. Alternatively, as outlined in Table 3, 13 items had a mode of 0,
indicating that participants did not report any change in these areas. A closer examination
of responses to individual items demonstrated that in some areas in which greater change
was reported by a high percentage of participants, a substantial number of individuals in
these same areas reported no change and vice versa.
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I have a greater appreciation for the value of my own life.

21.4

4.9

No Change Very Small

5.8

14.6

Small

Moderate

26.2

27.2

Great

Very Great

I more clearly see that I can count on people in times of trouble.

33.0
14.6

No Change

17.5

5.8

5.8

Small

Very Small

Moderate

23.3

Great

Very Great

27.2

30.1

Great

Very Great

I can better appreciate each day.

17.5

4.9

No Change Very Small

16.5

3.9

Small

Moderate

I learned a great deal about how wonderful people are.

15.5

24.3

28.2

Moderate

Great

Very Great

26.2
1.0

No Change Very Small

4.9

Small

Percent

Figure 1. Percentages for PTGI items with modes ≥ 4.
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Table 3
Frequencies and Percentages for PTGI Items With Modes Equal to Zeroa
Item
N (%)
Change in priorities
No change
Very small
Small
Moderate
Great
Very great
Developed new interests
No change
Very small
Small
Moderate
Great
Very great
Greater feeling of self-reliance
No change
Very small
Small
Moderate
Great
Very great
Better understanding of spiritual matters
No change
Very small
Small
Moderate
Great
Very great
Established a new path for my life
No change
Very small
Small
Moderate
Great
Very great
Greater sense of closeness with others
No change
Very small
Small
Moderate
Great
Very great
More willing to express emotion
No change
Very small
Small
Moderate
Great
Very great

35 (34.0)
5 (4.9)
8 (7.8)
20 (19.4)
18 (17.5)
17 (16.5)
54 (52.4)
5 (4.9)
13 (12.6)
11 (10.7)
14 (13.6)
6 (5.8)
54 (52.4)
5 (4.9)
5 (4.9)
16 (15.5)
14 (13.6)
9 (8.7)
45 (43.7)
3 (2.9)
6 (5.8)
10 (9.7)
23 (22.3)
16 (15.5)
48 (46.6)
2 (1.9)
5 (4.9)
20 (19.4)
15 (14.6)
13 (12.6)
32 (31.1)
3 (2.9)
9 (8.7)
20 (19.4)
24 (23.3)
15 (14.6)
38 (36.9)
3 (2.9)
7 (6.8)
31 (30.1)
20 (19.4)
4 (3.9)
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Table 3 (cont.)

Item
Know better that I can handle difficult situations
No change
Very small
Small
Moderate
Great
Very great
Able to do better things with my life
No change
Very small
Small
Moderate
Great
Very great
Better able to accept the way things work out
No change
Very small
Small
Moderate
Great
Very great
New opportunities are available
No change
Very small
Small
Moderate
Great
Very great
Stronger religious faithb
No change
Very small
Small
Moderate
Great
Very great
Discovered I am stronger than I thought I was
No change
Very small
Small
Moderate
Great
Very great
a
N = 103. bN = 102.

N (%)
33 (32.0)
5 (4.9)
8 (7.8)
23 (22.3)
27 (26.2)
7 (6.8)
43 (41.7)
7 (6.8)
8 (7.8)
23 (22.3)
11 (10.7)
11 (10.7)
33 (32.0)
3 (2.9)
7 (6.8)
28 (27.2)
20 (19.4)
12 (11.7)
62 (60.2)
6 (5.8)
7 (6.8)
9 (8.7)
12 (11.7)
7 (6.8)
42 (40.8)
2 (1.9)
7 (6.8)
10 (9.7)
23 (22.3)
18 (17.5)
37 (35.9)
2 (1.9)
7 (6.8)
20 (19.4)
24 (23.3)
13 (12.6)
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For example, although more than 50% of participants reported that they learned a
great deal about how wonderful people are to at least a great degree as a result of living
with HF, 26% reported no change in this area. Alternatively, although 44% of individuals
reported that they did not develop a better understanding of spiritual matters, more than
37% reported experiencing enhanced spirituality to a great or very great degree as a result
of their HF diagnosis.
To generate a better understanding of the type of personal growth experienced in
this population, descriptive statistics with Cronbach’s alpha coefficients were generated
for the PTGI subscales and are outlined in Table 4. Participants in this study reported the
greatest change in appreciation for life and the least amount of growth in new
possibilities. All of the mean per-item scores except for new possibilities fall on average
between a small (2) and moderate (3) degree of change.

Table 4
Characteristics of PTGI Subscales

Subscale

Mean (SD)

Cronbach’s


No. of
Items

Appreciation for life
Relating to others
Spiritual changea
Personal strength
New possibilities

8.53 (4.82)
18.32 (10.15)
4.32 (3.85)
8.50 (5.98)
8.97 (7.38)

.82
.91
.86
.82
.87

3
7
2
4
5

Note. N = 103.
a
N = 102

Mean
score
per-item

2.8
2.6
2.2
2.1
1.8

Percentage
of
maximum
subscale
score

56.9
52.3
43.2
42.5
35.9
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Demographic, Clinical, and Cognitive Factors Related to Personal Growth
Bivariate correlations were analyzed using Pearson product-moment correlation
coefficients for all continuous variables and dichotomous categorical variables to answer
the second research question, “To what extent are age, sex, ethnicity, disease severity,
time since diagnosis, symptom status, and uncertainty levels associated with personal
growth in individuals with HF?”
Assumptions for Correlation Analysis
Descriptive statistics and graphical displays were generated to assess for
violations of assumptions. Total personal growth scores, uncertainty scores, and total
symptom burden scores examined as part of the correlation analysis were at an interval
level of measurement. Age and time since diagnosis in years were also continuous
variables. Age was negatively skewed, with three outliers appearing to the far left of the
distribution and a significant Kolmogorov–Smirnov (K-S) statistic (p = .001). Age was
recoded to treat values ≤ to 50 years as a single, lowest age, leaving all other values as
reported.
Personal growth scores had a multimodal distribution and a significant K-S
statistic (p = .037), but near-zero skewness. The K-S test was also significant for
uncertainty scores (p = .026), but the histogram showed a fairly normal distribution, with
only slightly positive skewness and no outliers. One outlier appeared on the boxplot for
the total symptom burden score, but there was no significant difference between the mean
(2.01339) and 5% trimmed mean (2.01066) for this variable, so the case was not
excluded (Field, 2009). Given the sample size, departures from normality were within
acceptable limits. Scatterplots examining personal growth scores, age, symptom burden,
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and uncertainty did not show any obvious nonlinearity. (Field, 2009; Shadish, Cook, &
Campbell, 2002).
Sex and ethnicity (Hispanic or Latino vs. Not Hispanic or Latino) were
dichotomous. One participant preferred not to answer the question assessing ethnicity so
this case was excluded from the analysis. Only 4 participants met criteria for NYHA class
IV HF. As a result, disease severity was recoded by combining NYHA class III and IV
responses, resulting in a dichotomous variable with similar category frequencies. Time
since diagnosis was recoded into ordinal categories: 1 = 0-1 year, 2 = 2-3 years, 3 = 4-5
years, 4 = 6-9 years, 5 = 10-19 years, 6 = 20-29 years, and 7 = 30 or more years. Table 5
shows the descriptive statistics for continuous variables.
Correlation Results
Pearson product-moment correlation coefficients are outlined in Table 6. Results
showed that there was a small, negative correlation between age and total personal
growth scores (r = –.204, p < .05), indicating that younger participants reported higher
personal growth. Total symptom burden scores showed a small, positive correlation with
personal growth (r = .204, p < .05) and a moderate, positive association with uncertainty
scores (r = .492, p <.01), suggesting that a higher symptom burden is associated with
greater personal growth and increased levels of uncertainty. Disease severity showed a
small, positive correlation with age (r = .282, p < .01) and uncertainty scores (r = .279, p
< .01), indicating that more severe HF was related to older age and greater reports of
uncertainty. There were no significant associations between personal growth and sex,
ethnicity, time since diagnosis, or uncertainty.
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Table 5
Descriptive Statistics for Continuous Variables
Variable
Min Max Mean SE
Age
50
96
74.26 1.083
Time since
1
7
4.60 .171
a
diagnosis
Personal growth
0
105 48.64 2.820
Uncertainty
27
92
52.85 1.430
Symptom status .933 3.340 2.01 .0428

SD
10.99
1.734
28.616
14.241
.434

Skewness (SE) Kurtosis (SE)
–.536 (.238)
–.213 (.472)
–.376 (.238)
–.684 (.472)
–.061 (.238)
.237 (.238)
.007 (.238)

–1.075 (.472)
–.566 (.472)
.133 (.472)

Note. N = 103. SE = standard error; SD = standard deviation.
a
1 = 0-1 years, 2 = 2-3 years, 3 = 4-5 years, 4 = 6-9 years, 5 = 10-19 years, 6 = 20-29 years, 7 = ≥ 30 years.

Table 6
Pearson Product-Moment Correlation Matrix Between Measures of Personal Growth
and Age, Sex, Ethnicity, Disease Severity, Time Since Diagnosis, Symptom Status, and
Uncertainty
Variables
Personal
1
2
3
4
5
6
Growtha
1. Age
–.204*
2. Sex
.080
–.012
3. Ethnicity
–.120
.076
–.035
4. Disease severity
–.076
.282** .039
–.013
5. Time since diagnosis .038
.088
–.184 –.100 .168
6. Symptom statusb
.204*
–.151
.060
–.054 .185
–.015
c
7. Uncertainty
.057
.152
.027
–.138 .279** –.054 .492**
a

Personal growth as measured by the Posttraumatic Growth Inventory total growth score. bSymptom status
as measured by the Memorial Symptom Assessment Scale–Heart Failure total symptom burden score.
c
Uncertainty as measured by the Mishel Uncertainty in Illness Scale-Community Version.
*p < .05 (2-tailed). **p < .01 (2-tailed).

Predictors of Personal Growth in HF
Hierarchical multiple regression was conducted. Demographic variables (age, sex,
and ethnicity) were entered first, followed by clinical variables (disease severity and time
since diagnosis) and then total symptom burden scores and uncertainty scores, to answer
the third research question, “Which variables (age, sex, ethnicity, disease severity, time
since diagnosis, symptom status, or uncertainty levels) make independent contributions to
personal growth in individuals living with NYHA class II-IV HF?
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Assumptions for Multiple Regression
The final sample of 103 was satisfactory for 80% power to detect a medium
standardized effect size (f2 = .15, equivalent to a model R2 = .13 against a null hypothesis
that R2 = 0) at an alpha error level of .05 for a regression model with up to seven
predictors. Assumptions related to outliers, normality, linearity, homoscedasticity, and
multicollinearity were assessed.
As previously noted, there were no serious concerns about univariate normality
for the continuous variables and no obvious curvilinear bivariate relationships among
them. There were no significant multivariate outliers as determined by the maximum
Mahalanobis distance for the continuous variables (df = 4) and for the full regression
model (df = 7), based on chi-square critical values for p < .001 at the given degrees of
freedom as the cutoff.
The histogram of standardized residuals was approximately normally distributed
in relation to personal growth scores, albeit with fewer cases at the far right. The
scatterplot of standardized residuals by standardized predicted scores revealed scores
widely but essentially equally distributed across the ranges for the x and y axes,
consistent with the assumption of homoscedasticity. There was no indication of
problematic multicollinearity (maximum variance inflation factor = 1.51 for the full
model).
Multiple Regression Results
Hierarchical multiple regression was conducted. Demographic variables (age, sex,
and ethnicity) were entered in Step 1, explaining 5.8% of the variance in personal growth.
After entry of clinical variables (disease severity and time since diagnosis) in Step 2, the
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total variance explained by the model was 6.3%. Finally, after adding uncertainty and
symptom scores in Step 3, the total variance in personal growth explained by the model
as a whole was 9.5%, F(7, 95) = 1.430, p = .202. The model as a whole was not
statistically significant and individual regression coefficients in the model were also not
significant. See Table 7 for a summary of the regression model and Table 8 for
coefficients.

Table 7
Regression Model Summarya
Model
R
R2
b
Step 1
.241
.058
Step 2c
.251
.063
d
Step 3
.309
.095

R2 Change
.058
.005
.032

F Change
2.033
.254
1.701

df1
3
2
2

df2
99
97
95

p
.114
.777
.188

Note. N = 103.
a
Dependent variable: personal growth scores. bPredictors: age, sex, and ethnicity. cPredictors: age, sex,
ethnicity, disease severity, and time since diagnosis. dPredictors: age, sex, ethnicity, disease severity, time
since diagnosis, uncertainty, and symptom scores.

Additional Exploratory Analyses
Additional descriptive analyses were conducted to generate a better depiction of
symptom prevalence and burden and reports of uncertainty in this sample. In addition,
differences in personal growth scores were examined by sex, ethnicity, and disease
severity.
Symptom Prevalence and Burden
As outlined in Table 9, symptoms that were reported by at least 50% of the
participants included lack of energy (73.8%), feeling drowsy (58.3%), dry mouth
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Table 8
Regression Model Coefficientsa
Model
B
SE(B)
β
Step 1
Constant
93.406
23.715
Age
–.508
.255
–.195
Sex
4.944
6.483
.074
Ethnicity
–7.221
6.891
–.103
Step 2
Constant
86.454
25.830
Age
–.496
.268
–.191
Sex
5.890
6.670
.089
Ethnicity
–6.768
6.991
–.096
Years since diagnosis
1.117
1.689
.068
Disease severity
–2.163
5.921
–.038
Step 3
Constant
54.243
31.187
Age
–.391
.280
–.150
Sex
5.390
6.633
.081
Ethnicity
–6.279
7.042
–.089
Years since diagnosis
1.224
1.692
.074
Disease severity
–4.832
6.139
–.085
Symptom status
12.379
7.739
.188
Uncertainty
.000
.241
.000
_______________________________________________________

t

p

–1.994
.763
–1.048

.049
.448
.297

3.347
–1.852
.883
–.968
.661
–.365

.001
.067
.379
.335
.510
.716

1.739
–1.400
.813
–.892
.723
–.787
1.600
.001

.085
.165
.418
.375
.471
.433
.113
.999

Note. N = 103. SE = standard error.
a
Dependent variable: personal growth scores.

(55.3%), shortness of breath (52.4%), and worrying (50.5%). Individual symptom burden
scores as shown in Table 9 demonstrated acceptable internal consistency with Cronbach
alpha values > 0.8 for 16 symptoms, and > 0.7 for 12 symptoms. Symptoms with
Cronbach’s alpha values > 0.6 but less than 0.7 included feeling nervous, problems with
sexual interest or activity, weight loss, and waking up breathless at night. Symptoms that
were most burdensome included problems with sexual interest or activity (M = 2.81, SD
= 0.66), other pain (M = 2.51, SD = 0.7), lack of energy (M = 2.41, SD = 0.78), difficulty
sleeping (M = 2.4, SD = 0.73), and shortness of breath (M = 2.35, SD = 0.77). The mean
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for the total symptom burden scale was 2 (SD = .43), indicating that on average
participants reported symptoms occurring occasionally and as somewhat distressful and
moderately severe.
Uncertainty
In the current study, the Cronbach’s alpha coefficient for the MUIS-C was 0.92.
The mean for the MUIS-C was 52.85 (SD = 14.24), indicating that participants reported
moderate levels of uncertainty. Of the 23 items on the MUIS-C, 21 items had modal
categories of 2, indicating that a higher number of participants either disagreed with
statements that were indicative of greater uncertainty, such as, “I have a lot of questions
without answers” or “I am unsure if my illness is getting better or worse,” or agreed with
statements that were suggestive of greater certainty, such as “The purpose of each
treatment is clear to me.” In this sample, more than 50% of participants reported that they
strongly disagreed with the statement, “I don’t know what is wrong with me,” indicating
that participants were aware of their HF diagnosis.
Items that addressed the future had the highest percentage of individuals
responding with some degree of uncertainty. The item that was reflective of the highest
degree of uncertainty in this sample was “I am certain they will not find anything else
wrong with me,” with 46% of participants indicating that they disagreed with this
statement and 15% indicating that they strongly disagreed. The three other items that had
the highest reports of uncertainty included “The course of my illness keeps changing. I
have good days and bad days,” with 37% agreeing and 11% strongly agreeing with this
statement and “It is not clear what is going to happen to me” and “Because of the
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unpredictability of my illness, I cannot plan for the future,” with more than 30% of
participants either agreeing or strongly agreeing with both of these items.
Table 9
Prevalence and Burden of Symptoms and Reliability of Burden Scores
Symptom
Prevalence
Burden
Alpha
N
%
Mean
SD
Lack of energy
76
73.8
2.41
0.78
.88
60
58.3
Feeling drowsy
2.09
0.72
.80
57
55.3
Dry mouth
2.20
0.67
.76
54
52.4
Shortness of breath
2.35
0.77
.84
52
50.5
Worrying
2.16
0.61
.78
51
49.5
Dizziness
1.91
0.66
.82
49
48.0
Numbness or tingling in hands or feet
2.32
0.74
.72
46
44.7
Other pain
2.51
0.70
.74
43
42.2
Cough
2.03
0.70
.79
43
41.7
Difficulty sleeping
2.40
0.73
.82
43
41.7
Feeling irritable
2.03
0.59
.76
33
32.0
Feeling sad
2.06
0.69
.88
31
30.4
Swelling of arms or legs
1.99
0.83
.71
31
30.1
Itching
2.26
0.73
.81
28
28.3
Problems with sexual interest or activity
2.81
0.66
.64
29
28.2
Feeling nervous
2.15
0.54
.67
28
27.2
Difficulty concentrating
2.30
0.67
.76
28
27.2
Problem with urination
2.18
0.66
.72
27
26.2
Weight loss
1.30
0.49
.62
26
25.2
Weight gain
1.68
0.87
.77
24
23.5
Constipation
2.21
0.71
.84
24
23.3
Palpitations
1.82
0.58
.83
24
23.3
Lack of appetite
2.01
0.63
.74
23
22.3
Change in the way food tastes
2.00
0.71
.84
22
21.8
Difficulty breathing when lying flat
2.12
0.72
.79
21
20.4
Chest pain
1.95
0.72
.80
20
19.4
Feeling bloated
2.32
0.75
.82
18
17.5
Sweats
2.08
0.76
.82
13
12.6
Waking up breathless at night
2.14
0.53
.60
12
11.7
Diarrhea
1.87
0.74
.84
11
10.7
Nausea
2.02
0.58
.89
4
3.9
Vomiting
1.38
0.73
.93
Note. N = 103. Burden scores only calculated for participants who report symptoms.
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Differences in Personal Growth by Sex, Ethnicity, and Disease Severity
To highlight differences in personal growth by sample characteristics, additional
analysis was conducted. Differences in levels of personal growth by sex, ethnicity, and
disease severity were examined to assess whether statistically significant differences
existed in personal growth scores by groups using independent samples t tests.
Assumptions of Independent Samples t Tests
Each independent variable consisted of two groups; sex (male/female), ethnicity
(Hispanic/not Hispanic), and disease severity (NYHA class II/NYHA class III or IV).
The dependent variable, personal growth scores, was measured at an interval level. As
previously noted, there were no serious departures from normality assumptions. Levene’s
test for equality of variance by sex (F = .916, p = .34), by ethnicity (F = .489, p = .49),
and by disease severity (F = .603, p = .44) indicated that equal variances between groups
could be assumed (Pallant, 2007).
Results of Independent Samples t Tests
There was no significant difference in personal growth scores for males (M =
47.35, SD = 29.38) and females (M = 52.68, SD = 26.24); t(df = 101) = –.810, p = .42
(two-tailed). The magnitude of differences in the means (–5.334; 95% CI: –18.403 to
6.735) was small (Cohen’s d = .19).
Reports of personal growth also did not differ significantly by ethnicity, t(df =
100) = 1.486, p = .14 (two-tailed). Hispanic persons reported, on average, slightly higher
levels of personal growth (M = 57.21, SD = 26.28), compared with reports by individuals
not Hispanic (M = 46.43, SD = 28.98). The mean difference (10.777; 95% CI: –3.611 to
25.165) reflected a small-to-moderate effect size (Cohen’s d = .39).
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Participants meeting criteria for NYHA class II HF reported higher levels of
personal growth (M = 50.74, SD = 29.29) compared with those individuals with NYHA
class III of IV HF (M = 46.42, SD = 28.00), but this difference was not statistically
significant; t(df = 101) = .763, p = .44 (two-tailed). The mean difference (4.316; 95% CI:
–6.899 to 15.530), again, only represented a small effect size (Cohen’s d = .15). In
summary, there were no significant differences in reports of personal growth by sex,
ethnicity, or disease severity in this sample.
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CHAPTER 5
DISCUSSION

This study provided the first known examination of reports of personal growth in
community-residing adults living in the United States with a diagnosis of HF. Findings
highlighted the relevance of demographic and clinical factors to the development of
personal growth in HF. In addition, findings enhanced the theoretical understanding of
relationships among growth, uncertainty, and symptoms in chronic illness. This was the
first known study to quantitatively explore personal growth with respect to uncertainty
and symptoms in HF, providing empirical data that supported select relationships
proposed by Mishel (1990) in the RUIT.
Community-residing adults living with stable HF reported moderate levels of
personal growth, suggesting that individuals living with HF can perceive some degree of
favorable psychosocial change as a result of their illness experience. Personal growth
showed a weak negative association with age and a weak positive association with
symptom burden. Personal growth was not accounted for by disease severity, time since
diagnosis, uncertainty, symptom burden, or demographic variables other than age. Study
results are first reviewed in relation to past research examining personal growth in
cardiac populations and other illness groups and then in relationship to conceptualizations
and assumptions of personal growth belonging to Tedeschi and Calhoun’s (2004) model
of PTG and the RUIT (Mishel, 1990). Lastly, results are discussed in light of study
limitations.
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Reports of Personal Growth
This is the first study to explore personal growth exclusively in an HF population.
Personal growth has been studied previously in patients with cardiovascular disease,
including Canadian patients with a diagnosis of HF (n = 178) or other major
cardiovascular conditions (n = 1,090; Leung et al., 2010); U.S. (n = 28) and U.K. (n = 82)
patients with a history of heart disease or cardiac arrest who were enrolled in cardiac
rehabilitation or support group programs (Sheikh, 2004), and U.S. patients who had
experienced an MI (n = 205; Affleck et al., 1987).
PTGI scores in the current study (M = 48.6, SD = 28.6) were similar to those
reported by Leung et al. (2010; M = 50.3, SD = 27.2) but lower than those reported by
Sheikh (2004; M = 55.9, SD = 24.2). In the current study, participants reported the
greatest degree of personal growth in appreciation for life and the least amount of
personal growth in new possibilities. Leung et al. (2010) also found that participants
more commonly endorsed items on the appreciation for life subscale and less commonly
endorsed items related to new possibilities and spiritual change. Demographic
characteristics of participants within these three studies were similar; however,
participants in the current study were slightly older (M = 74.5, SD 10.99) compared with
participants in the studies by Leung et al. (2010; M = 67.3, SD = 11.16) and Sheikh
(2004; M = 63.5, SD = 9.7). In addition, although participants in the current study may
have had a history of cardiac surgery or cardiac arrest, these events were not accounted
for in the current study. By contrast, participants in the study by Sheikh (2004) had a
history of cardiac arrest, which may have contributed to greater adversity and therefore
higher reports of growth. The relationship between adversity and growth is discussed in
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more detail in upcoming sections examining personal growth in relation to the RUIT and
PTG model.
Compared with studies cited by Leung et al. (2010) that used the PTGI in other
patient populations, PTGI scores in the present study were higher than have been reported
among patients with hepatobiliary cancer, prostate cancer survivors, and HIV/AIDS, but
lower compared with those that have been reported for breast cancer, stage IV liver
cancer, colorectal cancer, bone marrow transplant, and multiple sclerosis. However,
variations in study design and sample characteristics make it difficult to generalize from
such comparisons. That said, results of this study provide a preliminary baseline for
future study of personal growth in HF and add to the overall literature on personal growth
in chronic illness.
Correlates of Personal Growth
Age
Personal growth showed a weak, negative correlation with age in this study,
indicating that younger participants reported more growth. This finding is consistent with
results reported by Leung et al. (2010) in cardiac patients, with studies in cancer
survivors and HIV populations that measured growth with the PTGI (Barskova &
Oesterreich, 2009), and with research in breast cancer survivors that used the GTUS to
assess growth (Porter et al., 2006).
Petrie et al. (1999) conducted the only other study that examined the relationship
between growth (as measured by a single item question) and age in a cardiac sample
(individuals 3 months post-MI) living in New Zealand and did not find a significant
association between the two variables. Several studies conducted with other illness
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populations demonstrated nonsignificant associations between age and growth, but only
one of these studies used the PTGI (Barskova & Oesterreich, 2009).
Sex
In the current study, personal growth was not significantly associated with sex,
consistent with findings demonstrated in other cardiac populations (Leung et al., 2010;
Petrie et al., 1999; Sheikh, 2004) and in bone marrow transplant patients (Widows et al.,
2005). However, the current study had a small number of female participants (n = 25;
24.3%) which may have limited the ability to detect differences in personal growth by
sex. In contrast, Barskova and Oesterreich (2009) found that among cancer survivors and
HIV patients women tended to report greater growth than men in their systematic review
of PTG in serious illness.
Ethnicity
There was no significant relationship between personal growth and ethnicity or
differences in growth scores by ethnicity in the current study. However, the majority of
participants (n = 96; 93.2%) were White and were not Hispanic (n = 83; 80.6%). In
contrast, Leung et al. (2010) reported significant differences in personal growth by race
(their Canadian sample did not include Hispanic participants), with Asian participants
reporting the highest growth, followed by African American participants, and then White
participants. According to Barskova and Oesterreich (2009), studies that had only a small
percentage of minority participants tended not to find significant associations between
growth and race or ethnicity, whereas studies in cancer and HIV populations that found
greater growth in African-Americans and Hispanics compared with Whites included
larger numbers of ethnically/racially diverse participants.
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Disease Severity
Disease stage was not significantly associated with personal growth in the current
study, congruent with results reported by Petrie et al. (1999), who did not find significant
differences between reports of growth and illness severity in an MI population. Two
studies using the PTGI in cancer groups demonstrated nonsignificant associations with
disease stage (Thornton & Perez, 2006; Widows et al., 2005), whereas one study using
the PTGI demonstrated greater growth in individuals with stage II cancer compared with
stage I or stage IV cancer (Lechner et al., 2003). Overall, evidence that disease stage at
the time of study participation impacted growth is equivocal at best.
Time Since Diagnosis
Time since diagnosis was not significantly associated with personal growth in HF,
consistent with findings from earlier studies in cardiac and cancer populations, in which
growth was measured using the PTGI (Lechner et al., 2003; Morris et al., 2007; Sheikh,
2004). Alternatively, studies in breast cancer survivors 2 years post-diagnosis (Cordova
et al., 2001) and 18 months after diagnosis (Sears et al., 2003), and in brain injury
patients at 10 to 11 years post-insult (McGrath & Linley, 2006; Powell et al., 2007) have
shown significant correlations between longer time since diagnosis and reports of greater
growth. In the present study, a majority of participants (56.3%) had been living with HF
for more than 10 years, and more than 30% of the sample had been living with HF for
more than 20 years. The extended length of time that participants had to adjust to their
HF diagnosis may have influenced the nonsignificant findings between time since
diagnosis and personal growth in the current study. In addition, cross-sectional data
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collection may have limited the ability to detect associations between time since
diagnosis and personal growth.
Symptom Status and Uncertainty
No other studies were found that examined the relationship between personal
growth and uncertainty or symptom status in HF. Studies investigated variables such as
disease severity and morbidity (Affleck et al., 1987) and functional abilities (Leung et al.,
2010) that may be influenced by symptoms, but that influence cannot be teased out after
the fact. Therefore, this is the only study that specifically examined the relationships
among personal growth, uncertainty, and symptom status in HF. Symptom status had a
weak positive correlation with personal growth (r = .204, p < .05), but correlations
between uncertainty and growth were not significant.
Theoretical Implications of Study Results
The primary guiding framework for this study was Mishel’s (1990) RUIT. In
addition to the RUIT, Tedeschi and Calhoun’s (2004) conceptualization of PTG and
related assumptions also informed this study. In this section, study results are reviewed in
relation to these concepts and other studies that have been informed by the RUIT.
Theoretically derived variables included in this analysis were disease severity, time since
diagnosis, symptom status, uncertainty, and personal growth.
The first aim of this study was to determine whether individuals living with HF
report personal growth, as characterized within the above conceptual frameworks.
Tedeschi and Calhoun (1996, 2004) suggested that personal growth represents a process
in which individuals move beyond traditional coping/adaptation to achieve positive
psychosocial outcomes in response to significant adversity. Congruent with this
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conceptualization of growth, Mishel (1990) argued that over time, individuals living with
ongoing uncertainty in chronic illness may be able to perceive opportunities for growth
through the discovery of new life meaning.
Based on the literature, which suggests that HF is associated with significant
mortality, symptom burden, uncertainty due to an unpredictable illness trajectory, high
rates of depression, and poor quality of life (Adler et al., 2009), this study was rooted in
the assumption that living with a diagnosis of HF could create significant challenges that
subsequently disrupt an individual’s fundamental beliefs about his or her health and
future, and encourage personal growth. Descriptive statistics of disease severity,
symptom status, and uncertainty (variables that the literature suggests contribute to the
challenges of HF) helped to depict the presence of these negative factors within this HF
sample.
Adversity in HF
In terms of disease severity, approximately 52% of the sample met criteria for
NYHA class II HF, indicating that they had slight limitations with usual activity due to
symptoms, whereas the other half met criteria for either NYHA class III or IV HF,
indicating that they had at least moderate limitations with less than usual activity due to
their symptoms.
As shown in Table 9, participants reported a variety of symptoms. The symptoms
reported most commonly (lack of energy, feeling drowsy, dry mouth, shortness of breath,
and worrying) were consistent with symptom prevalence findings reported by Zambroski
et al. (2005), who also used the MSAS-HF to assess symptoms in an outpatient HF
population. The most burdensome symptoms in the current study were problems with
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sexual interest/activity, pain, lack of energy, difficulty sleeping, and shortness of breath.
Zambroski et al. (2005) also reported that these symptoms were among the most
burdensome in their sample. In general, mean burden scores in Zambroski et al.’s (2005)
study were higher than were those reported in the current study. Variations in mean
burden scores could result from the higher number of participants (77.4%) with either
NYHA class III-IV HF in Zambroski et al.’s (2005) sample compared with the current
study.
The mean for the MUIS-C was 52.85 (SD = 14.24), indicating that participants
reported moderate levels of uncertainty. Uncertainty levels were essentially consistent
with uncertainty levels measured by the MUIS-C (M = 54.9, SD = 7.7) reported by
Winters (1999) in an outpatient HF population and lower than uncertainty scores (M =
71.4, SD = 9.56) reported by Jurgens (2006) in hospital inpatients with HF.
In summary, this HF sample reported slight to moderate limitations in activity
from their symptoms. Symptom prevalence and burden reports and levels of uncertainty
were comparable to other outpatient HF populations. These results support a finding that
negative factors thought to contribute to distress in HF were present to a small to
moderate degree in this sample.
Reports of Personal Growth
In this study, participants reported a moderate degree of personal growth. The
areas of greatest growth involved appreciation for life followed by relationships with
others, spiritual change, and personal strength. These results are congruent with results of
qualitative studies that either informed the development of the RUIT or used the RUIT as
a guiding framework, which found that some individuals living with uncertainty in
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chronic illness perceive positive outcomes (Baier, 1995; Bailey et al. 2007; Brashers et
al., 1999; Fleury et al., 1995; Mishel & Murdaugh, 1987). Positive perceptions in these
studies included hope or optimism for the future, lifestyle change, personal or spiritual
growth, and finding joy in small accomplishments, but were typically described in
conjunction with more pervasive negative thoughts or emotions. The PTGI, which was
used to evaluate personal growth in the current study, did not account for concurrent
negative perceptions or outcomes.
Results from the current study also supplement the literature that has
quantitatively examined uncertainty in relationship to growth in other illness populations,
specifically in men with prostate cancer (Bailey et al. 2004) and breast cancer survivors
(Gil et al., 2006, Mast 1998, Porter et. al, 2006), using Mishel and Fleury’s (1994)
GTUS. A synthesis of these findings is discussed below.
Correlates and Predictors of Personal Growth
In the RUIT, Mishel (1990) suggests that disease severity and symptom status can
contribute to greater levels of uncertainty, but that over time, individuals may be able to
positively reappraise uncertainty and perceive growth. Time since diagnosis was
examined in the current study to assess the influence of time on this process in HF. Time
since diagnosis was not significantly associated with growth in the current study,
consistent with findings demonstrated by Mast (1998), who measured growth via the
GTUS in breast cancer survivors. However, both of these studies used cross-sectional
data collection, which may have limited the ability to detect findings related to growth
over time. In addition, although personal growth evolves over time, time in and of itself
may not be sufficient to produce personal growth on its own.
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Disease severity was also not significantly related to personal growth in this
study; however, NYHA class did demonstrate significant relationships with age and
uncertainty, indicating that individuals with more severe HF were older and had higher
levels of uncertainty. This finding supports relationships outlined in Mishel’s (1988,
1990) UIT and RUIT. In these theories, disease severity and symptom status are included
as components of the stimuli frame, which is characterized as an antecedent of
uncertainty. Consistent with findings from this study, Mishel (1988, 1990) proposes that
greater illness severity increases uncertainty. The positive association between disease
severity and uncertainty in this study is also consistent with the fact that with increased
duration of chronic HF, the frequency of sudden, acute exacerbations tends to increase
and intervening periods of stability may be shorter in duration (Hupcey et al., 2009;
Jessup et al., 2009).
Symptom burden showed a weak positive association with personal growth.
However, in the regression model, symptom burden did not account for significant
variance in personal growth after controlling for demographic and clinical factors and
uncertainty. The overall negative finding indicates that variables that were not included in
this analysis may account for personal growth in HF. Symptom burden did demonstrate a
moderate, positive correlation with uncertainty, suggesting that higher symptom burden is
associated with greater uncertainty. This finding also supports the relationship outlined
by Mishel (1988, 1990) between symptoms and uncertainty and is congruent with the
literature, which suggests that symptoms can contribute to uncertainty in HF (Aldred et
al., 2005; Beckelman, Nowels, Retrum et al., 2011; Brännström et al., 2006; Brännström
et al., 2007; Falk et al., 2007; Jurgens, 2006; Russell et al., 1998; Winters, 1999).
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There was no significant association between uncertainty and personal growth in
the current study. This finding contrasts with a previous study of uncertainty as a
component of a negative cognitive state, which showed an association between
uncertainty and less growth, a relationship that was mediated by higher symptom distress
and less social support satisfaction in breast cancer survivors (Porter et al., 2006). Mishel
(1990) proposed that reappraising uncertainty requires a cognitive restructuring of reality
that occurs over time and that achieving growth through uncertainty is supported by selforganization (integrating uncertainty into one’s life) and probabilistic thinking; in
addition, the propensity for growth may be influenced by past life experience,
physiologic states, social support, and interactions with health care providers. With the
exception of disease severity and symptom burden as measures of physiologic state, these
other factors were not assessed in the current study, which could have contributed to the
nonsignificant findings.
Other researchers who have studied symptoms and uncertainty as correlates or
predictors of growth, as characterized within the RUIT, have included variables thought
to facilitate psychosocial well-being or positive reappraisal (Bailey et al. 2004; Gil et al.,
2006; Mast, 1998; Porter et. al, 2006). For example, Porter et al. (2006) demonstrated that
greater symptom prevalence, when combined with increased religious participation,
higher levels of education, and younger age, was significantly associated with increased
reports of growth in breast cancer survivors. In addition, cognitively reframing events in
a positive way helped to explain growth in both African American and White breast
cancer survivors and mediated the influence of social support and religious involvement
on personal growth (Porter et al., 2006). Examining variables thought to facilitate
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psychosocial health and cognitive reframing may be necessary to better understand
personal growth in HF.
In conclusion, this study found that community-residing adults with stable HF
report on average moderate levels of personal growth that is not explained by age, sex,
ethnicity, time since diagnosis, symptom burden, or uncertainty. Several factors could
help to explain why reports of personal growth were not higher in this HF sample and
why study variables did not help to explain variance in personal growth.
The overall stability of this HF sample could suggest that participants did not
experience adversity significant enough to challenge their fundamental worldviews, a
prerequisite required for PTG as described by Tedeschi and Calhoun (2004). The long
duration of time that most participants had been living with HF could have supported
more traditional adjustment to their illness not characterized by personal transformations
necessary for growth. In addition, growth may have been a more salient feature in earlier
stages of HF that, for a majority of patients, would have occurred many years earlier.
In addition, characteristics of the cardiology clinic and/or providers that were not
accounted for in this study but observed by the researcher could have minimized potential
adversity. Patients were routinely evaluated by consistent providers who had been
affiliated with the clinic for several years. In addition, practitioners provided patients with
ongoing education related to their HF diagnosis and management and comprehensive
follow-up for changes in their clinical condition. On several occasions during research
interviews, participants made unsolicited remarks about their satisfaction with and
confidence in the care provided by the cardiology clinic. At the same time, providers
predominantly focused on managing the physical consequences of HF, rather than on
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providing psychosocial or cognitive support, which is consistent with national guidelines
for the treatment of HF (Heart Failure Society of America, 2010a, 2010b; Jessup et al.,
2009). Therefore, variables not included in this analysis, such as psychological, social or
spiritual support, or interventions that promote cognitive reappraisal may be more
important in the development of personal growth. Bekelman, Nowels, Allen et al. (2011)
found that individuals living with HF receiving outpatient palliative care services
reported significant needs related to psychosocial support which was lacking in
traditional HF management. Integrating supportive care into HF management programs
might help to facilitate personal growth.
Limitations
Several limitations need to be considered when interpreting results from this
study. Most notably, convenience sampling of participants who could speak and
understand English from one private practice cardiology clinic in San Antonio, TX,
reduced the external validity of findings (Shadish et al., 2002). Participants were
predominantly White, male, married or living with a partner, educated at or above a high
school level, and older, limiting the ability to generalize findings to more diverse
populations. The small number of female, Hispanic, and Class IV HF participants may
have limited the ability to detect significant relationships between growth and sex,
ethnicity, and disease severity in this study. In addition, the cardiology clinic has been
well established in the community for many years and has a strong reputation for
providing quality cardiac care. Characteristics of the clinic and its providers could have
also influenced results, especially related to symptom burden and uncertainty reports.
Results might differ in settings that do not provide the same level of comprehensive,
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coordinated HF management, limiting the ability to generalize findings to more diverse
settings.
Reliability of the MSAS-HF has been established for the total symptom
prevalence score and the physical, psychological, and HF-specific subscales (Zambroski
et al., 2005). Because the total symptom burden score on the MSAS-HF depends on
unique combinations of symptoms for each respondent, an overall reliability coefficient
cannot be estimated. This is a potential threat to statistical conclusion validity. However,
reliability coefficients for the burden scores of individual symptoms could be estimated,
and most were, satisfactory (especially in view of being based on just 2 or 3 items per
symptom).
Investigator expectancy (Shadish et al., 2002) is a plausible threat to construct
validity in this study. Participants who chose to complete the survey via a researcherconducted interview in the clinic rather than independently may have been inclined to
respond to items differently due to the presence of the researcher or clinic staff. In
particular, participants may have been more inclined to provide favorable responses to
items on the MUIS-C, which asked specific questions about their HF management.
To minimize these risks, participants were given the option of completing the
survey independently, either electronically or on paper. In addition, when the participant
opted for a researcher-conducted interview, the researcher read the survey directions and
questions exactly as they were written on the survey. Interviews were conducted in
private rooms before or after patients were evaluated by their providers and participants
were assured that their responses would not be shared with clinic staff. To assess for this
threat, independent samples t tests were conducted to examine differences in PTGI,
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MUIS-C, and MSAS-HF scores by survey administration methods. No significant
differences in questionnaire scores between participants who completed the survey
independently on paper and those who participated in a researcher-conducted interview
were found. Only 2% of participants completed the survey electronically, so this group
was excluded from this analysis. These findings suggest that threats to construct validity
resulting from unintended researcher/staff expectancies were most likely limited.
Although the aims of this descriptive, exploratory study were not to test causal
relationships, threats to internal validity also need to be considered when interpreting
results. As described above, convenience sampling was used to enroll participants,
potentially contributing to selection bias (Shadish et al., 2002). Individuals who perceived
their HF experience as more positive may have been more interested in participating. To
ensure that all potentially eligible participants were informed of the study, recruitment
letters were sent to individuals meeting diagnostic criteria for HF; recruitment flyers were
also available in all patient rooms and the waiting room and were given to all HF patients
by providers during scheduled visits.
In addition to selection bias, threats to ambiguous temporal precedence could
influence internal validity. Cross-sectional data collection limited inferences regarding
both the onset of growth and its trajectory in HF over time (Shadish et al., 2002).
Although the PTGI asked participants to rate the degree of positive change in response to
their HF diagnosis in this study, other adverse life events not accounted for within this
research may have influenced participants’ responses.
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Implications for Future Research
This study provides the first known examination of personal growth exclusively
in HF and specifically in relation to symptoms and uncertainty. Findings provide a
beginning understanding of personal growth in HF by demonstrating that communityresiding adults living with stable HF report moderate levels of personal growth that is not
explained by demographics, time since diagnosis, disease stage, uncertainty, or symptom
burden. The results create a foundation for future research to build on in advancing our
understanding of personal growth in HF. A more in-depth knowledge of personal growth
in HF may be useful in informing supportive care models being developed to supplement
traditional medical management of HF. Enhanced understanding of personal growth
could help to clarify how nurses and other health care providers facilitate or hinder
personal growth for patients with HF.
To improve the ability to generalize findings, researchers should examine
personal growth in more diverse HF populations that include a greater number of female
participants and greater racial and ethnic diversity as well as greater variability in clinical
condition (e.g., with more recently diagnosed or less stable patients). Reports of personal
growth and correlates should also be examined in individuals living in rural and
underserved regions and receiving care within public, academic, or hospital-based
settings. Larger, more representative samples from multiple settings would also enhance
the generalizability of findings.
Incorporating a greater range of sociodemographic and psychosocial variables
(e.g., income, social support, coping strategies, and personality dispositions) might
provide a more comprehensive representation of personal growth in HF and help to
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identify potential mediating/moderating factors and predictors of growth. A better
understanding of growth through uncertainty in relation to adversity would most likely
result from studies that assess personal growth using both the PTGI and GTUS.
Longitudinal assessment of personal growth beginning at the time of diagnosis and at
regular intervals thereafter would generate a better understanding of the onset and
trajectory of growth within HF. In addition to replicating quantitative assessments of
growth, qualitative approaches that garner a deeper understanding of participants’
experiences of growth would strengthen the science of personal growth in chronic illness.
Finally, future research should include qualitative approaches and/or instruments that also
assess cognitive processes, such as rumination, positive reappraisal, or probabilistic
thinking to better understand how personal growth develops and to test relationships
proposed by Tedeschi and Calhoun (2004) and Mishel (1990).
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APPENDIX A
RECONCEPTUALIZED UNCERTAINTY IN ILLNESS CONCEPTUAL MODEL

Reprinted from Bailey, D. E., & Stewart, J. (2014). Uncertainty in illness. In M. R.
Alligood (Ed.), Nursing theorists and their work (8th ed., pp. 555-573). St. Louis, MO:
Elsevier, Mosby. Copyright Merle Mishel, 1990.
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APPENDIX B
UNCERTAINTY IN ILLNESS CONCEPTUAL MODEL

Reprinted with permission from: Mishel, M. H. (1988). Uncertainty in illness.
Image: The Journal of Nursing Scholarship, 20(4), 225-232.
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RECRUITMENT FLYER
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COMBINED INFORMED CONSENT AND HIPAA AUTHORIZATION
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APPENDIX F
POSTTRAUMATIC GROWTH INVENTORY

Indicate for each of the statements below the degree to which this change occurred in
your life as a result of your heart failure diagnosis, using the following scale.
0= I did not experience this change as a result of my crisis.
1= I experienced this change to a very small degree as a result of my crisis.
2= I experienced this change to a small degree as a result of my crisis.
3= I experienced this change to a moderate degree as a result of my crisis.
4= I experienced this change to a great degree as a result of my crisis.
5= I experienced this change to a very great degree as a result of my crisis.
1. I changed my priorities
about what is important in life.

0

1

2

3

4

5

2. I have a greater appreciation
for the value of my own life.

0

1

2

3

4

5

3. I developed new interests.

0

1

2

3

4

5

4. I have a greater feeling of self-reliance. 0

1

2

3

4

5

5. I have a better understanding
of spiritual matters.

0

1

2

3

4

5

6. I more clearly see that I can count
on people in times of trouble.

0

1

2

3

4

5

7. I established a new path for my life.

0

1

2

3

4

5

8. I have a greater sense of closeness
with others.

0

1

2

3

4

5

9. I am more willing to express
my emotions.

0

1

2

3

4

5
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10. I know better that I can
handle difficulties.
11. I am able to do better things
with my life.

0

1

2

3

4

5

0

1

2

3

4

5

12. I am better able to accept
the way things work out.

0

1

2

3

4

5

13. I can better appreciate each day.

0

1

2

3

4

5

14. New opportunities are available
0
which wouldn't have been otherwise.

1

2

3

4

5

15. I have more compassion for others.

0

1

2

3

4

5

16. I put more effort into my
relationships.

0

1

2

3

4

5

17. I am more likely to try to change
things which need changing.

0

1

2

3

4

5

18. I have a stronger religious faith.

0

1

2

3

4

5

19. I discovered that I'm stronger
than I thought I was.

0

1

2

3

4

5

20. I learned a great deal about
how wonderful people are.

0

1

2

3

4

5

21. I better accept needing others.

0

1

2

3

4

5

163
APPENDIX G
MISHEL UNCERTAINTY IN ILLNESS SCALE–COMMUNITY FORM

MISHEL UNCERTAINTY IN ILLNESS SCALE–
COMMUNITY FORM
INSTRUCTIONS:
Please read each statement. Take your time and think about what each
statement says. Then place an “X” under the column that most closely
measures how you are feeling TODAY.
If you agree with a statement, then you would mark under either “Strongly
Agree” or “Agree.” If you disagree with a statement, then mark under either
“Strongly Disagree” or “Disagree.”
If you are undecided about how you feel, then mark under “Undecided” for
that statement. Please respond to every statement.
1. I don’t know what is wrong with me.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)

Disagree
(2)

______

______

Strongly Disagree
(1)
______

2. I have a lot of questions without answers.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)

Disagree
(2)

______

______

Strongly Disagree
(1)
______

3. I am unsure if my illness is getting better or worse.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)

Disagree
(2)

______

______

Strongly Disagree
(1)
______
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4.

It is unclear how bad my pain will be.
Strongly Agree
(5)
_______

5.

Agree
(4)
______

Undecided
(3)

Disagree
(2)

______

Strongly Disagree
(1)

______

______

The explanations they give about my condition seem hazy to me.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)

Disagree
(2)

______

Strongly Disagree
(1)

______

______

6. The purpose of each treatment is clear to me.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)

Disagree
(2)

______

Strongly Disagree
(1)

______

______

7. My symptoms continue to change unpredictably.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)

Strongly Disagree
(1)

______

______

8. I understand everything explained to me.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)

Disagree
(2)

______

______

Strongly Disagree
(1)
______

9. The doctors say things to me that could have many meanings.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______
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10. My treatment is too complex to figure out.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

11. It is difficult to know if the treatments or medications I am getting are
helping.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)

Disagree
(2)

______

______

Strongly Disagree
(1)
______

12. Because of the unpredictability of my illness, I cannot plan for the future.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

13. The course of my illness keeps changing. I have good and bad days.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

14. I have been given many differing opinions about what is wrong with me.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)

Disagree
(2)

______

______

Strongly Disagree
(1)
______

15. It is not clear what is going to happen to me.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______
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16. The results of my tests are inconsistent.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)

Strongly Disagree
(1)

______

______

17. The effectiveness of the treatment is undetermined.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)

Strongly Disagree
(1)

______

______

18. Because of the treatment, what I can do and cannot do keeps changing.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)

Disagree
(2)

______

______

Strongly Disagree
(1)
______

19. I’m certain they will not find anything else wrong with me.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)

Strongly Disagree
(1)

______

______

20. The treatment I am receiving has a known probability of success.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

21. They have not given me a specific diagnosis.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)

Disagree
(2)

______

______

Strongly Disagree
(1)
______
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22. The seriousness of my illness has been determined.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

23. The doctors and nurses use everyday language so I can understand what they
are saying.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______
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MEMORIAL SYMPTOM ASSESSMENT SCALE–HEART FAILURE
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APPENDIX I
COMBINED REDCAPTM SURVEY
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APPENDIX J
MEDICAL RECORD REVIEW FORM: ADDITIONAL CLINICAL DATA

